Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-12-234633.txt : 20120515 0001193125-12-234633.hdr.sgml : 20120515 20120515161900 ACCESSION NUMBER: 0001193125-12-234633 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-30489 FILM NUMBER: 12844991 BUSINESS ADDRESS: STREET 1: 10813 S. RIVER FRONT PARKWAY STREET 2: STE. 500 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 858-312-8000 MAIL ADDRESS: STREET 1: 10813 S. RIVER FRONT PARKWAY STREET 2: STE. 500 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 10-Q 1 d346854d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

x	QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

Commission file number 000-30489

LIFEVANTAGE CORPORATION

(Exact name of Registrant as specified in its charter)

COLORADO

90-0224471

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

9815 S. Monroe Street, Ste 100, Sandy, UT 84070

(Address of principal executive offices)

(801) 432-9000

(Registrant’s telephone number)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares outstanding of the issuer’s common stock, par value $0.001 per share, as of May 8, 2012 was 110,067,349.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this report and the information incorporated by reference herein may contain “forward-looking statements” (as such term is defined in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended). These statements, which involve risks and uncertainties, reflect our current expectations, intentions, or strategies regarding our possible future results of operations, performance, and achievements. Forward-looking statements include, without limitation: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending; statements regarding our product development strategy; statements regarding the future performance of our network marketing sales channel; and statements regarding future financial performance, results of operations, capital expenditures and sufficiency of capital resources to fund our operating requirements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and applicable rules of the Securities and Exchange Commission and common law.

These forward-looking statements may be identified in this report and the information incorporated by reference by words such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “plan”, “predict”, “project”, “should” and similar terms and expressions, including references to assumptions and strategies. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements.

The following factors are among those that may cause actual results to differ materially from our forward-looking statements:

•

Limited operating history;

•

Our ability to successfully expand our operations;

•

Difficulty in managing growth and expansion;

•

We reported material weaknesses in our internal control over financial reporting, and if we are unable to improve our internal control over financial reporting, our financial results may not be accurately reported;

•

Reliance on information technology systems;

•

We may need to raise additional capital;

•

The deterioration of global economic conditions and the decline of consumer confidence and spending;

•

Environmental liabilities stemming from past operations and property ownership;

•

Significant dependence upon a single product;

•

Competition in the dietary supplement market;

•

The potential failure or unintended negative consequences of our network marketing sales channel;

•

Our ability to retain independent distributors or to attract new independent distributors on an ongoing basis;

•

The potential for government or third party actions against us resulting from independent distributor activities that violate applicable laws or regulations;

•

Our business is subject to strict government regulations;

•

Our ability to continue to innovate and provide products that are useful to consumers;

•

Our ability to protect our intellectual property rights and the value of our product;

•

The effect of current and future government regulations of the network marketing and dietary supplement industries on our business;

•

The effect of unfavorable publicity on our business;

•

We are subject to the risk of investigatory and enforcement action by the Federal Trade Commission;

•

The potential for third party and governmental actions involving our network marketing sales channel;

•

The potential for product liability claims against us;

•

Our dependence on third party manufacturers to manufacture our product;

•

The ability to obtain raw material for our product;

•

Product returns may adversely affect our business;

•

Loss of key personnel could negatively impact our business;

•

We may not succeed in growing existing markets or opening new markets;

•

Economic, political and other risks associated with international operations could adversely affect our business;

•

Our stock is classified as a penny stock;

•

If we need additional financings in the future it could result in additional dilution;

•

If holders of our existing warrants and options exercise their securities it would materially dilute the outstanding voting shares and could cause our stock price to decline;

•

The market price of our securities could be adversely effected by the sales of restricted securities;

•

Our stock price may experience future volatility;

•

The illiquidity of our common stock;

•

Substantial sales of shares of our common stock;

•

We have not nor do we intend to issue dividends; and

•

Other factors not specifically described above, including the other risks, uncertainties, and contingencies described under “Description of Business”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Items 1 and 7 of our Annual Report on Form 10-K for the year ended June 30, 2011.

When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.

LIFEVANTAGE CORPORATION

INDEX


		PAGE
PART I. Financial Information			4
Item 1.	Financial Statements:		4
	Condensed Consolidated Balance Sheets (unaudited) — March 31, 2012 and June 30, 2011		4
	Condensed Consolidated Statements of Operations and Other Comprehensive Income (unaudited) — For the Three and Nine Month Periods Ended March 31, 2012 and 2011		5
	Condensed Consolidated Statement of Stockholders’ Equity — For the Nine Month Period Ended March 31, 2012		6
	Condensed Consolidated Statements of Cash Flows (unaudited) — For the Nine Month Periods Ended March 31, 2012 and 2011		7
	Notes to Condensed Consolidated Financial Statements (unaudited)		8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		16
Item 4.	Controls and Procedures		16
PART II. Other Information			17
Item 1.	Legal Proceedings		17
Item 1A.	Risk Factors		17
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		18
Item 3.	Defaults Upon Senior Securities		18
Item 4.	Mine Safety Disclosures		18
Item 5.	Other Information		18
Item 6.	Exhibits		18
Signatures			19

PART I Financial Information

Item 1. Financial Statements

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)


	As of,
	March 31, 2012			June 30, 2011
ASSETS
Current assets
Cash and cash equivalents	$	16,896,369		$	6,370,974
Marketable securities, available for sale		—			350,000
Accounts receivable, net		817,158			941,802
Inventory		6,980,520			2,124,663
Current deferred income tax asset		2,237,494			—
Prepaid expenses and deposits		1,948,426			487,812

Total current assets		28,879,967			10,275,251
Long-term assets
Property and equipment, net		1,766,609			227,811
Intangible assets, net		1,912,399			1,963,277
Long-term deferred income tax asset		474,506			—
Deposits		342,173			32,173

TOTAL ASSETS	$	33,375,654		$	12,498,512

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	—		$	799,210
Commissions payable		4,433,803			1,999,969
Reserve for sales returns		764,894			435,135
Accrued bonuses		1,835,480			782,852
Other accrued expenses		3,643,826			1,423,370
Other current liabilities		90,691			69,893
Revolving line of credit and accrued interest		—			433,984
Short-term derivative liabilities		—			7,435,883

Total current liabilities		10,768,694			13,380,296
Long-term liabilities
Other long-term liabilities		76,430			21,017
Derivative liabilities		—			19,905,401

Total liabilities		10,845,124			33,306,714

Commitments and contingencies
Stockholders’ equity (deficit)
Preferred stock — par value $0.001 per share, 50,000,000 shares authorized, no shares issued or outstanding		—			—
Common stock — par value $0.001 per share, 250,000,000 shares authorized and 109,219,361 and 98,794,499 issued and outstanding as of March 31, 2012 and June 30, 2011, respectively		109,898			98,795
Additional paid-in capital		104,260,897			67,606,293
Accumulated deficit		(81,792,667	)		(88,453,607	)
Accumulated other comprehensive loss		(47,598	)		(59,683	)

Total stockholders’ equity (deficit)		22,530,530			(20,808,202	)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$	33,375,654		$	12,498,512

The accompanying notes are an integral part of these condensed consolidated statements.

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	For the three months ended March 31,						For the nine months ended March 31,
	2012			2011			2012			2011
Sales, net	$	36,211,615		$	9,975,224		$	81,578,972		$	23,878,662
Cost of sales		4,988,548			1,581,866			11,624,980			3,793,535

Gross profit		31,223,067			8,393,358			69,953,992			20,085,127
Operating expenses:
Sales and marketing		19,676,246			5,350,388			44,096,845			12,781,834
General and administrative		4,616,165			2,081,108			10,491,795			5,084,270
Research and development		378,098			115,515			924,450			315,025
Depreciation and amortization		146,063			54,084			322,740			157,984

Total operating expenses		24,816,572			7,601,095			55,835,830			18,339,113

Operating income		6,406,495			792,263			14,118,162			1,746,014
Other income (expense):
Interest income (expense)		21,310			(468,900	)		8,570			(2,477,805	)
Change in fair value of derivative liabilities		(10,686,945	)		(10,090,924	)		(6,740,525	)		(2,777,953	)

Total other income (loss)		(10,665,635	)		(10,559,824	)		(6,731,955	)		(5,255,758	)

Net income (loss) before income taxes		(4,259,140	)		(9,767,561	)		7,386,207			(3,509,744	)

Income tax (expense) benefit		(586,653	)		—			250,806			(95,000	)

Net income (loss)	$	(4,845,793	)	$	(9,767,561	)	$	7,637,013		$	(3,604,744	)

Net income (loss) per share, basic	$	(0.05	)	$	(0.13	)	$	0.08		$	(0.05	)

Net income (loss) per share, diluted	$	(0.05	)	$	(0.13	)	$	0.07		$	(0.05	)

Weighted average shares, basic		103,016,170			73,181,511			100,450,870			69,281,640
Weighted average shares, diluted		103,016,170			73,181,511			115,232,578			69,281,640

Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment		(80,278	)		(17,359	)		12,085			(24,825	)

Other comprehensive income (loss)	$	(80,278	)	$	(17,359	)	$	12,085		$	(24,825	)

Comprehensive income (loss)	$	(4,926,071	)	$	(9,784,920	)	$	7,649,098		$	(3,629,569	)

The accompanying notes are an integral part of these condensed consolidated statements.

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND COMPREHENSIVE INCOME

(UNAUDITED)


	Common Stock					Additional Paid In Capital			Accumulated Deficit			Accumulated Other Comprehensive Income/(Loss)			Total
	Shares			Amount		Additional Paid In Capital			Accumulated Deficit			Accumulated Other Comprehensive Income/(Loss)			Total
Balances, June 30, 2011		98,794,499		$	98,795	$	67,606,293		$	(88,453,607	)	$	(59,683	)	$	(20,808,202	)
Options/Warrants issued for services		—			—		880,891			—			—			880,891
Exercise of options and warrants		10,954,535			10,954		19,295,791			—			—			19,306,745
Issuance of restricted stock		149,253			149		(149	)		—			—			—
Repurchase of company stock		(678,926	)		—		—			(976,073	)		—			(976,073	)
Reclassification of liability warrants		—			—		16,478,071			—			—			16,478,071
Currency translation adjustment		—			—		—			—			12,085			12,085
Net income		—			—		—			7,637,013			—			7,637,013

Balances, March 31, 2012		109,219,361			109,898		104,260,897			(81,792,667	)		(47,598	)		22,530,530

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	For the nine months ended March 31,
	2012			2011
Cash Flows from Operating Activities:
Net income (loss)	$	7,637,013		$	(3,604,744	)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		322,740			157,984
Stock based compensation to employees		748,212			397,183
Stock based compensation to non-employees		132,679			53,597
Deferred income tax benefit		(2,712,000	)		—
Amortization of deferred offering costs		—			583,738
Non-cash interest expense		—			1,644,158
Change in fair value of derivative liabilities		6,740,525			2,777,953
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable		124,644			(402,390	)
(Increase) in inventory		(4,855,857	)		(977,880	)
(Increase) in prepaid expenses and deposits		(1,770,614	)		(266,637	)
Increase in other liabilities		61,440			940
(Decrease) increase in accounts payable		(799,210	)		104,101
Increase in accrued expenses		6,036,677			1,977,148

Net Cash Provided by Operating Activities		11,666,249			2,445,151
Cash Flows from Investing Activities:
Redemption of marketable securities		350,000			75,000
Purchase of intangible assets		(49,389	)		(24,208	)
Purchase of equipment		(1,743,718	)		(64,743	)

Net Cash Used in Investing Activities		(1,443,107	)		(13,951	)
Cash Flows from Financing Activities:
Net payments proceeds from revolving line of credit and accrued interest		(433,984	)		—
Principal payments under capital lease obligation		(2,782	)		—
Excess tax benefits from stock-based compensation		309,565			—
Repurchase of company stock		(976,073	)		—
Issuance of common stock and warrants		—			50,000
Exercise of options and warrants		1,393,442			—

Net Cash Provided by Financing Activities		290,168			50,000
Foreign Currency Effect on Cash		12,085			(24,825	)
Increase in Cash and Cash Equivalents:		10,525,395			2,456,375
Cash and Cash Equivalents — beginning of period		6,370,974			1,637,676

Cash and Cash Equivalents — end of period	$	16,896,369		$	4,094,051

Non Cash Investing and Financing Activities:
Conversion of debt to common stock	$	—		$	2,329,365
Conversion of derivative to common stock	$	—		$	3,804,936
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest expense	$	—		$	276,625
Cash paid for income taxes	$	2,280,000		$	56,000

The accompanying notes are an integral part of these condensed consolidated statements.

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THREE AND NINE MONTHS ENDED MARCH 31, 2012 AND 2011

(UNAUDITED)

These unaudited Condensed Consolidated Financial Statements and Notes should be read in conjunction with the audited financial statements and notes of LifeVantage Corporation as of and for the year ended June 30, 2011 included in our annual report on Form 10-K.

Note 1 — Organization and Basis of Presentation:

The condensed consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the management of LifeVantage Corporation (“LifeVantage” or the “Company”), these interim financial statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair presentation of our financial position as of March 31, 2012, and the results of operations for the three and nine month periods ended March 31, 2012 and 2011 and the cash flows for the nine month periods ended March 31, 2012 and 2011. Interim results are not necessarily indicative of results for a full year or for any future period.

The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in our audited financial statements and notes for the fiscal year ended June 30, 2011 pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June 30, 2011, and included in the Annual report on Form 10-K on file with the SEC.

Note 2 — Summary of Significant Accounting Policies:

Consolidation

The accompanying financial statements include the accounts of LifeVantage Corporation and our wholly-owned subsidiaries Lifeline Nutraceuticals Corporation (“LNC”), LifeVantage de México, S. de R.L. de C.V. (Limited Liability Company), Importadora LifeVantage, S. de R.L. de C.V. (Limited Liability Company), and Servicios Administrativos para la Importación de Productos Body & Skin, S.C. All inter-company accounts and transactions between the entities have been eliminated in consolidation.

Translation of Foreign Currency Statements

We translate the financial statements of our foreign entities by using the current exchange rate. For assets and liabilities, the exchange rate at the balance sheet date is used. For any investment in subsidiaries and retained earnings, the historical exchange rate is used. For revenue, expenses, gains, and losses, an appropriately weighted average exchange rate for the period is used.

Use of Estimates

Management has made a number of estimates and assumptions relating to the reporting of revenues, expenses, assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements. Actual results could differ from those estimates.

Fair Value Measurements

Fair value measurement requirements are embodied in certain accounting standards applied in the preparation of our financial statements. Significant fair value measurements include our embedded derivative liabilities. See Note 4 — Stockholders Equity for disclosures related to our common stock and warrant financing arrangements. The fair value hierarchy is defined below:

Fair value hierarchy:

(1) Level 1 inputs are quoted prices in active markets for identical assets and liabilities.

(2) Level 2 inputs are inputs which include quoted prices for similar assets and liabilities in active markets and inputs that are observable for the assets or liabilities, either directly or indirectly, for substantially the full term of the financial instrument.

(3) Level 3 inputs are unobservable inputs and significant to the fair value measurement.

The financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. There were no financial instrument measured at fair value at March 31, 2012.

The summary of fair values of financial instruments is as follows at June 30, 2011:


Instrument:	Fair value		Carrying Value		Level		Valuation Methodology
Investments	$	350,000	$	350,000		2	Market price
Derivative liabilities	$	27,341,284	$	27,341,284		3	Black-Scholes Dilution adjusted

The following represents a reconciliation of the changes in fair value of financial instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended March 31, 2012 and the year ended June 30, 2011:


	March 31, 2012			June 30, 2011
Beginning balance: Derivative liabilities	$	27,341,284		$	18,567,450
Total (gains) losses		6,740,525			48,454,271
Reclassification of liability to equity		(16,478,071	)		—
Purchases, sales, issuances and settlements, net		(17,603,738	)		(39,680,437	)

Ending balance: Derivative liabilities	$	—		$	27,341,284

Warrants issued with convertible debentures that we issued from November 2009 through February 2010 were amended effective December 29, 2011. The amendment removed certain price-based anti-dilution provisions which had resulted in the warrants being treated as liabilities and as a result the fair value of the warrants was reclassified to equity as of December 29, 2011. Warrants issued in association with a common stock financing in March and April of 2009 and which had expirations of March and April 2012 have all been exercised as of March 31, 2012 and as a result there is no derivative liability as of that date.

Cash and Cash Equivalents

We consider only our monetary liquid assets with original maturities of three months or less as cash and cash equivalents.

Accounts Receivable

Accounts receivable at March 31, 2012 consist primarily of credit card receivables including a holdback by the credit card processor. The holdback balance at March 31, 2012 was $500,000. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its direct and independent distributor sales as of March 31, 2012 is not necessary. No bad debt expense has been recorded for the three and nine months ended March 31, 2012 or the year ended June 30, 2011.

Investments

In 2008 we invested in auction rate preferred securities of closed-end funds (“ARPS”) to maximize interest income. As of March 31, 2012 all these investments have been sold.

Inventory

Inventory is stated at the lower of cost or market value. Cost is determined using the first-in, first-out method. We have capitalized payments to our contract product manufacturer for the acquisition of raw materials and commencement of the manufacturing, bottling and labeling of our product. As of March 31, 2012 and June 30, 2011, inventory consisted of:


	March 31, 2012		June 30, 2011
Finished goods	$	3,584,305	$	736,103
Raw materials		3,396,215		1,388,560

Total inventory	$	6,980,520	$	2,124,663

Revenue Recognition

We ship the majority of our product directly to the consumer via UPS and receive substantially all payment for these sales in the form of credit card charges. Revenue from direct product sales to customers is recognized upon passage of title and risk of loss to customers when product is shipped from the fulfillment facility. Sales revenue and estimated returns are recorded when product is shipped. Our return policy is to provide a 30-day money back guarantee on orders placed by customers. After 30 days, we do not issue refunds to direct sales customers for returned product. In the network marketing sales channel, we allow terminating distributors to return unopened unexpired product that they have purchased within the prior twelve months, subject to certain consumption limitations. To date, returns from terminating distributors have been negligible. Our return rate for sales directly to consumers and sales through our network channel are based on our historical experience which we analyze on a regular basis. As of March 31, 2012 and June 30, 2011, our reserve balance for returns and allowances was $764,894 and $435,135, respectively.

Income per share

Basic income or loss per share is computed by dividing the net income or loss by the weighted average number of common shares outstanding during the period. Diluted earnings per common share are computed by dividing net income by the weighted average common shares and potentially dilutive common share equivalents. For the three month period ended March 31, 2012 the effects of approximately 25 million common shares issuable upon exercise of warrants issued in our private placement offerings and options granted through our 2007 and 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive. For the nine month period ended March 31, 2012 the effects of approximately 120,000 common shares, respectively, issuable upon exercise of options granted through our 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive. For the three and nine month periods ended March 31, 2011 the effects of approximately 62 million common shares, respectively, issuable upon exercise of warrants issued in our private placement offerings, compensation based warrants issued and options granted through our 2007 and 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive.

Segment Information

Our operations are aggregated into a single reportable operating segment based upon similar economic and operating characteristics as well as similar markets. Our operations are also subject to similar regulatory environments. We conduct our operations in the Americas which includes the U.S., Canada and Mexico and in Japan. Substantially all long-lived assets are located in the U.S. Revenues by geographic area are as follows:


	Three months ended March 31,				Nine months ended March 31,
	2012		2011		2012		2011
Americas operations	$	25,745,524	$	8,150,636	$	59,612,464	$	19,223,278
Japan operations		10,466,091		1,824,588		21,966,508	$	4,655,384

Total revenues	$	36,211,615	$	9,975,224	$	81,578,972	$	23,878,662

Research and Development Costs

We expense all costs related to research and development activities as incurred. Research and development expenses for the nine month periods ended March 31, 2012 and 2011 were $924,450 and $315,025, respectively.

Shipping and Handling

Shipping and handling costs associated with inbound freight and freight out to customers, including independent distributors, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.

Stock-Based Compensation

In certain circumstances, we issued common stock for invoiced services and in other similar situations to pay contractors and vendors. Payments in equity instruments to non-employees for goods or services are accounted for using the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued.

Derivative Financial Instruments

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. However, we have entered into certain other financial instruments and contracts, such as freestanding warrants and embedded conversion features on convertible debt instruments that are not afforded equity classification. These instruments are required to be carried as derivative liabilities, at fair value, in our consolidated financial statements.

Derivative financial instruments consist of financial instruments or other contracts that contain a notional amount and one or more underlying variables (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets.

We estimate fair values of derivative financial instruments using various techniques that are considered to be consistent with the objective measurement of fair values. In selecting the appropriate technique, we consider, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as freestanding warrants, we generally use the Black Scholes Merton option valuation technique, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, and risk free rates) necessary to fairly value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock. Since derivative financial instruments are initially and subsequently carried at fair values, our income or loss will reflect the volatility in changes to these estimates and assumptions.

As of March 31, 2012 all financial instruments subject to fair value treatment had been exercised or amended and we have no derivative instruments subject to fair value liability treatment.

Income Taxes

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items which are recorded in the interim period. The provision for income taxes for the three months ended March 31, 2012 and 2011 differs from the amount that would be provided by applying the statutory U.S. federal income tax rate of 34% to pre-tax income primarily because of state income taxes, estimated permanent differences and change in valuation allowance.

The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in various jurisdictions, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known or as the tax environment changes.

As of March 31, 2012 we have recognized a net income tax benefit of $250,806 which is our estimated federal and state income tax liability for the nine months ended March 31, 2012 combined with the income tax benefit resulting from the reduction in the valuation allowance in the previous quarter. Realization of our deferred tax asset is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain. In December 2011, we determined it was more likely than not that the deferred tax asset would be realized and as a result we released the valuation allowance we had established resulting in a net benefit of $2,802,000 which represents the benefit expected to be realized in future years. As of March 31, 2012 the net deferred tax benefit was $2,712,000.

Effective January 1, 2009, we account for any uncertainty in income taxes by recognizing the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits recognized in the financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. The application of income tax law is inherently complex. As such, we are required to make subjective assumptions and judgments regarding income tax exposures. The result of the reassessment of our tax positions did not have an impact on the consolidated financial statements.

Concentration of Credit Risk

approximately $897,154 in foreign bank accounts and $5,000,120 in an investment management account at another financial institution. As of March 31, 2012 and June 30, 2011 the Company’s cash balances exceeded federally insured limits.

Effect of New Accounting Pronouncements

We have reviewed recently issued, but not yet effective, accounting pronouncements and do not believe any such pronouncements will have a material impact on our financial statements.

Note 3 — Line of Credit

We established a line of credit to borrow up to 80% of our investments in certain marketable securities. The line was collateralized by the proceeds of the repurchase of the marketable securities. The line was paid in full in January 2012, in conjunction with the settlement of the marketable securities and is now closed.

Note 4 — Stockholders’ Equity

During the three and nine months ended March 31, 2012 we issued 8,571,884 and 9,405,035 shares of common stock, respectively, upon the exercise of warrants. During the three and nine months ended March 31, 2012 we issued 888,500 and 1,549,500 shares of common stock, respectively, upon the exercise of stock options. During the three and nine month periods ended March 31, 2012 we repurchased 228,926 and 678,926 shares of our common stock, respectively, at a total cost of $325,000 and $976,073, respectively. The cost of the shares is classified against our accumulated deficit as of March 31, 2012 as we have effectively retired these shares. During the three and nine months ended March 31, 2012 we issued 149,253 shares of restricted stock. The restricted stock vests in equal annual installments over four years

Our Articles of Incorporation authorize the issuance of preferred shares. However, as of March 31, 2012, none have been issued nor have any rights or preferences been assigned to the preferred shares by our Board of Directors.

In December 2011, certain outstanding warrants were amended removing price-based anti-dilution protection in exchange for a one month increase in the life of the warrants. As a result of this amendment, the warrants became classified as equity rather than a liability. In conjunction with the amendment, we marked the warrants to fair value, including the inducement, as of the date of the amendment, and then reclassified the liability of $16,478,071 to additional paid in capital.

Note 5 — Stock-based Compensation

We adopted and the shareholders approved the 2007 Long-Term Incentive Plan (the “2007 Plan”), effective November 21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 10,000,000 shares of our common stock can be issued under the 2007 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2007 Plan and are outstanding to employees, officers, directors, independent distributors and Scientific Advisory Board (“SAB”) members at prices between $0.21 and $0.76 per share, vesting over one- to three-year periods. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2007 Plan upon expiration of the award. As of March 31, 2012, awards for the purchase of an aggregate of 6,997,600 shares of our common stock are outstanding under the 2007 Plan.

We adopted and the shareholders approved the 2010 Long-Term Incentive Plan (the “2010 Plan”), effective September 27, 2010, to provide incentives to eligible employees, directors and consultants. As of March 31, 2012 a maximum of 6,900,000 shares of our common stock were available for issuance under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to employees, officers and directors at prices between $0.63 and $1.75 per share, vesting over ten month- to four-year periods. As of March 31, 2012, awards for the purchase of an aggregate of 3,874,003 shares of our common stock are outstanding under the 2010 Plan. At our annual meeting of shareholders in January 2012 our shareholders approved a 3,400,000 share increase in the number of shares available for issuance under the 2010 Plan, increasing the total number of shares reserved from 3,500,000 to 6,900,000 shares.

Payments in equity instruments for goods or services are accounted for under the guidance of share based payments, which require use of the fair value method. We have adjusted the expense for the anticipated forfeitures. Compensation based options and restricted stock totaling 1,822,003 and 1,935,003 shares were granted for the three and nine month periods ended March 31, 2012, respectively. Compensation based options totaling 44,000 and 102,000 shares were granted for the three and nine month periods ended March 31, 2011, respectively.

For the three and nine months ended March 31, 2011, stock based compensation of $288,665 and $450,780, respectively, was reflected as an increase to additional paid in capital. Of the stock based compensation for the three and nine months ended March 31, 2011, $264,666 and $397,183, respectively, was employee related and $23,999 and $53,597, respectively, was non-employee related.

Compensation expense was calculated using the fair value method during the three and nine month periods ended March 31, 2012 and 2011 using the Black-Scholes option pricing model. The following assumptions were used for options and warrants granted during the nine month periods ended March 31, 2012 and 2011:

risk-free interest rates of between 0.93 and 1.55 percent for the nine months ended March 31, 2012 and between 1.33 and 2.64 percent for the nine months ended March 31, 2011;

dividend yield of -0- percent;

expected life of 3 to 6 years; and

a volatility factor of the expected market price of our common stock of between 127 and 137 percent for the nine months ended March 31, 2012 between 125 and 129 percent for the nine months ended March 31, 2011.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis contains forward-looking statements within the meaning of the federal securities laws. We urge you to carefully review our description and examples of forward-looking statements included in the section entitled “Cautionary Note Regarding Forward-Looking Statements” at the beginning of this report. Forward-looking statements speak only as of the date of this report and we undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this report. Actual events or results may differ materially from such statements. In evaluating such statements, we urge you to specifically consider various factors identified in this report, including the matters set forth below in Part II, Item 1A of this report, any of which could cause actual results to differ materially from those indicated by such forward-looking statements. The following discussion and analysis should be read in conjunction with the accompanying financial statements and related notes, as well as the Financial Statements and related notes in our Annual report on Form 10-K for the fiscal year ended June 30, 2011 and the risk factors discussed therein.

Overview

The following discussion and analysis reviews the financial condition and results of operations of LifeVantage Corporation (the “Company”, “LifeVantage”, or “we”, “us” or “our”) and its wholly-owned subsidiaries Lifeline Nutraceuticals Corporation (“LNC”), LifeVantage de México, S. de R.L. de C.V. (Limited Liability Company), Importadora LifeVantage, S. de R.L. de C.V. (Limited Liability Company), and Servicios Administrativos para la Importación de Productos Body & Skin, S.C.

We are a science-based company engaged in the identification, research, development, manufacture and distribution of an advanced nutraceutical dietary supplement, Protandim^® the Nrf2 Synergizer^™, and an anti-aging skin care product, LifeVantage TrueScience^®, to meet important health and wellness needs. We are focusing our ongoing research efforts on oxidative stress solutions, particularly the activation of Nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as they relate to cardiovascular, central nervous system, inflammatory, metabolic diseases and other health related disorders.

We sell our products primarily through our network marketing sales channel utilizing independent distributors. Our revenue depends significantly upon the number and productivity of our independent distributors who market and sell our products and attract new distributors based on the distinguishing benefits and innovative characteristics of our products. We have developed a distributor compensation plan and other incentives designed to motivate our independent distributors to market and sell our products and to build sales organizations. If we experience delays or difficulties in introducing compelling products or attractive initiatives to independent distributors, our revenue and our business may be adversely affected.

Our Products

Our products are Protandim^® and LifeVantage TrueScience^® Anti-Aging Cream, or LifeVantage TrueScience^®, which incorporates ingredients in Protandim^® and other proprietary ingredients. Protandim^® is a proprietary blend of ingredients that has been shown to combat oxidative stress by increasing the body’s natural antioxidant protection at the genetic level, inducing the production of naturally-occurring protective antioxidant enzymes including superoxide dismutase, catalase, and glutathione synthase.

We sell Protandim^® and LifeVantage TrueScience^® primarily through our network marketing sales channel to our independent distributors and to preferred and retail customers.

To date, we have focused our research efforts on investigating various aspects and consequences of the imbalance of oxidants and antioxidants which is a central underlying feature in many disorders. Specifically we have targeted the ability of Protandim^® to activate Nrf2. Nrf2 is a master regulator of the antioxidant response, which is important for the amelioration of oxidative stress. We intend to continue our research, development, and documentation of the efficacy of Protandim^® to provide credibility to the market. We also anticipate undertaking research, development, testing, and licensing efforts to be able to introduce additional products in the future.

Protandim^® has been, is currently, or is planned to be the subject of, approximately 25 independent scientific studies at various universities and research facilities. The nature and stages of the studies vary, as some are still in planning stages, while other studies are currently in progress or completed. The universities and institutions involved in this research include the University of Colorado; Colorado State University; Children’s Hospital, Denver; Virginia Commonwealth University; Louisiana State University; Ohio State University; Northwestern University; the University of Utah; Harvard University; and VU University Medical Center, Amsterdam. The various studies address the alleviation of oxidative stress under the following conditions: altitude sickness, non-alcoholic steatohepatitis, lung antioxidant status in withdrawing alcoholics, autonomic physiology and aging, skin cancer, multiple sclerosis, pulmonary hypertension, heart disease, coronary artery bypass graft failure, Duchenne muscular dystrophy, capsular contracture, and experimental allergic encephalomyelitis.

Net revenue from Protandim^®, TrueScience^® and related marketing materials totaled $36,211,615 and $81,578,972, respectively, for the three and nine months ended March 31, 2012, and $9,975,224 and $23,878,662, respectively, for the three and nine months ended March 31, 2011.

Three and Nine Months Ended March 31, 2012 Compared to Three and Nine Months Ended March 31, 2011

Revenue We generated net revenue of $36,211,615 during the three months ended March 31, 2012, and generated net revenue of $9,975,224 during the three months ended March 31, 2011. We generated net revenue of $81,578,972 during the nine months ended March 31, 2012 and $23,878,662 during the nine months ended March 31, 2011. The increases in revenue of $26,236,391 and $57,700,310 for the three and nine months ended March 31, 2012 compared to the three and nine months ended March 31, 2011 are due to increased volume through the network marketing sales channel in the Americas and Japan. Sales in the Americas accounted for $17,594,888 and $38,583,273, respectively, of the increase. Our sales in Japan accounted for $8,641,503 and $19,135,711, respectively, of the increase. During the quarter ended March 31, 2012 we adjusted our returns reserve and as a result we booked approximately $581,000 less in reserves than we would have using our prior estimate. During the three and nine month periods ended March 31, 2012, substantially all of our sales and marketing effort was directed toward building our network marketing sales channel.

Gross Margin Our gross profit percentage for the three month periods ended March 31, 2012 and 2011 was 86% and 84%, respectively. Our gross profit percentage for the nine months ended March 31, 2012 and 2010 was 86% and 84%, respectively. The slightly higher gross margins we have experienced in fiscal year 2012 are primarily due to efficiencies and reductions in warehousing and distribution costs as a percentage of revenue. We expect the gross margin percentages for our network marketing sales channel to remain in this range for the foreseeable future.

Operating Expenses Total operating expenses for the three months ended March 31, 2012 were $24,816,572 as compared to operating expenses of $7,601,095 for the three months ended March 31, 2011. Total operating expenses during the nine month period ended March 31, 2012 were $55,835,830 as compared to operating expenses of $18,339,113 during the nine month period ended March 31, 2011. Operating expenses consist of sales and marketing expenses, general and administrative expenses, research and development, and depreciation and amortization expenses. The increase was primarily due to commissions paid to distributors on the higher sales volume as well as increases in headcount and related expenses as we have continued to experience high growth. We expect our operating expenses to continue to increase relative to sales increases and as we continue to grow.

Sales and Marketing Expenses Sales and marketing expense increased from $5,350,388 for the three months ended March 31, 2011 to $19,676,246 for the three months ended March 31, 2012. Sales and marketing expenses increased from approximately $12,781,834 for the nine months ended March 31, 2011 to $44,096,845 for the nine months ended March 31, 2012. These increases were due primarily to commissions paid to distributors due to the higher sales volume as well as increased expenses associated with headcount as we continue to hire to support our growth. We expect continued increases in sales and marketing expenses as our sales increase.

General and Administrative Expenses Our general and administrative expense increased from $2,081,108 for the three months ended March 31, 2011 to $4,616,165 for the three months ended March 31, 2012. General and administrative expense increased from $5,084,270 for the nine months ended March 31, 2011 to $10,491,795 for the nine months ended March 31, 2012. The increases were due primarily to increased headcount costs as we have continued to hire to support our growth, increased legal and professional fees directly related to our growth and rent expense on our new office space.

Research and Development Our research and development expenses increased from $115,515 for the three months ended March 31, 2011 to $378,098 for the three months ended March 31, 2012. Research and development expenses increased from $315,025 for

the nine months ended March 31, 2011 to $924,450 for the nine months ended March 31, 2012. The increases are primarily a result of an increase in salary and benefits. Research and development is a company priority and we have ensured that sufficient cash is available for the remainder of this fiscal year to fund research and development efforts of up to approximately 2% of our total net revenue. The recognition and timing of these expenses will be dependent upon entry into specific research and development projects.

Depreciation and Amortization Expense Depreciation and amortization expense increased from $54,084 during the three months ended March 31, 2011 to $146,063 during the three months ended March 31, 2012. Depreciation and amortization expense increased from $157,984 for the nine months ended March 31, 2011 to $322,740 for the nine months ended March 31, 2012. These increases were due primarily to capital acquisitions made during the three and nine month periods ended March 31, 2012 related to our continuing growth and new leased office space in Utah.

Net Other Income (Expense) We recognized net other expense of $10,665,635 during the three months ended March 31, 2012 as compared to $10,559,824 during the three months ended March 31, 2011. During the nine months ended March 31, 2012 we recognized net other expense of $6,731,955 as compared to net other expense of $5,255,758 for the nine months ended March 31, 2011. These fluctuations between periods are primarily the result of the change in fair value of the derivative liabilities during the three and nine months ended March 31, 2012 of $10,686,945 and $6,740,525, respectively. The large change in fair value of derivative liabilities in the quarter ended March 31, 2012 was due to the exercise of all remaining warrants which had been classified as derivative liabilities.

Income Tax Benefit (Expense) We recognized income tax expense of $586,653 and an income tax benefit of $250,806, respectively, for the three and nine months ended March 31, 2012 as compared to expense of none and $95,000 for the three and nine months ended March 31, 2011, respectively. The net benefit recognized was due to the one-time release of our valuation allowance against deferred tax assets of $2,802,000 during the nine months ended March 31, 2012 and was offset by tax expense of $586,653 and $2,462,047 for the three and nine months ended March 31, 2012, respectively.

Net Income We recorded net loss of $4,845,793 for the three month period ended March 31,2012 compared to net loss of $9,767,561 for the three month period ended March 31, 2011. We recorded net income of $7,637,013 for the nine month period ended March 31, 2012 compared to net loss of $3,604,744 for the nine month period ended March 31, 2011.

Liquidity and Capital Resources

Our primary liquidity and capital resource requirements are to finance our continued expansion into the network marketing sales channel. This includes the costs associated with additional support personnel, compensating our distributors, the manufacture and sale of our products, capital investments in systems and infrastructure and general and administrative expenses. In order to remain cash flow positive from operations, we must maintain or continue to increase sales and maintain or limit expense increases.

Our primary source of liquidity is cash generated from the sales of our products. As of March 31, 2012, our available liquidity was $16,896,369, including available cash and cash equivalents. This represented an increase of $10,525,395 from the $6,370,974 in cash and cash equivalents as of June 30, 2011. During the nine months ended March 31, 2012, our net cash provided by operating activities was $11,666,249 as compared to net cash provided by operating activities of $2,445,151 during the nine months ended March 31, 2011. Our cash provided by operating activities during the nine month period ended March 31, 2012 increased primarily as a result of increased revenues.

During the nine months ended March 31, 2012, our net cash used in investing activities was $1,443,107, due to the purchase of equipment and intangible assets offset by proceeds from the redemption of marketable securities. During the nine months ended March 31, 2011, our net cash used by investing activities was $13,951 primarily due to the purchase of equipment and intangible assets offset by proceeds from the redemption of marketable securities.

Cash used by financing activities during the nine months ended March 31, 2012 was $290,168 compared to cash provided by financing activities of $50,000 during the nine months ended March 31, 2011. Cash used by financing activities during the nine month period ended March 31, 2012 was related to the repurchase of company stock and the payment of our line of credit, offset by proceeds received from the exercise of options and warrants and an excess tax benefit from stock-compensation.

We have a line of credit that was secured by the proceeds from the repurchase of marketable securities that we held. The line of credit was paid off in full in January 2012.

At March 31, 2012, we had working capital (current assets minus current liabilities) of $18,111,273, compared to negative working capital (current liabilities in excess of current assets) of $3,105,045 at June 30, 2011. The working capital at March 31, 2012 is due primarily to the increase in cash and inventory and the release of our valuation allowance against current deferred tax assets.

Our ability to finance future operations will depend on our existing liquidity and on our ability to generate continued revenues and profits from operations. We believe that existing cash on hand and future cash flow will be sufficient to allow us to continue

operations for at least the next 12 months. A shortfall from projected sales levels would likely result in expense reductions, which could have a material adverse effect on our ability to continue operations at current levels. If we are unable to generate cash from operations at projected or otherwise sufficient levels, we may be required to seek additional funds through debt, equity or equity-based financing (such as convertible debt); however financing may not be available on favorable terms or at all. If we raise additional funds by selling additional shares of our capital stock, or securities convertible into shares of our capital stock, the ownership interest of our existing shareholders will be diluted. The amount of dilution could be increased by the issuance of warrants or securities with other dilutive characteristics, such as anti-dilution clauses or price resets.

Off-Balance Sheet Arrangements

As of March 31, 2012, we did not have any off-balance sheet arrangements.

Recently Issued Accounting Standards

We have reviewed recently issued, but not yet effective, accounting pronouncements and do not believe any such pronouncements will have a material impact on our financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Under the rules and regulations of the SEC, as a smaller reporting company we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of March 31, 2012, we conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of March 31, 2012 at the reasonable assurance level due to the material weaknesses in our internal control over financial reporting discussed immediately below.

Identified Material Weaknesses

A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of our financial statements would not be prevented or detected on a timely basis by our employees in the normal course of performing their assigned functions. Management identified material weaknesses during our assessment of our internal control over financial reporting as of March 31, 2012. In particular, we concluded that we did not maintain:

Sufficient personnel with an appropriate level of accounting knowledge, experience and training in the selection and application of technical accounting principles in accordance with GAAP to support our financial accounting and reporting functions given that we did not continue to hire sufficient personnel considering our rapid growth; and

Adequate oversight of certain accounting functions and did not maintain adequate documentation of management review and approval of accounting transactions and financial reporting processes.

In conclusion, our Chief Executive Officer and Chief Financial Officer determined that we did not maintain effective internal control over financial reporting as of March 31, 2012.

Management’s Remediation Initiatives

We are in the process of evaluating our material weaknesses. We have already begun to remediate the material weaknesses. In an effort to remediate the identified material weaknesses and other deficiencies and to enhance our internal control over financial reporting, we have initiated, or plan to initiate, the following series of measures:

Hire staff with experience managing and working in the corporate accounting department of a publicly traded company; and

Implement appropriate management oversight and approval activities.

In April 2012 we hired an Assistant Controller with manager level public accounting experience which included audits of publicly traded companies. We anticipate that the above initiatives will be implemented by June 2012. Additionally, we plan to test our updated controls and remediate our material weaknesses by June 30, 2012.

Conclusion

The above identified material weaknesses resulted in material audit adjustments to our 2011 financial statements. If the identified material weaknesses are not remediated, one or more of the identified material weaknesses noted above could result in a material misstatement in our reported financial statements in a future interim or annual period.

In light of the identified material weaknesses, management performed (1) significant additional substantive review of those areas described above, and (2) additional analyses, including but not limited to a detailed balance sheet and statement of operations analytical review that compared changes from the prior period’s financial statements and analyzed all significant differences. These procedures were completed so management could gain assurance that the financial statements and schedules included in this report fairly present in all material respects our financial position, results of operations and cash flows for the periods presented.

Changes in Internal Control over Financial Reporting

We made no changes during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

PART II Other Information

Item 1. Legal Proceedings

There have been no material changes to the legal proceeding discussed in our quarterly report on Form 10-Q for the quarter ended December 31, 2011.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in “Part I. Item 1A—Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2011. The risks and uncertainties described in such risk factors and elsewhere in this report have the potential to materially affect our business, financial condition, results of operations, cash flows, projected results and future prospects. As of the date of this report, we do not believe that there have been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2011.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the period covered by this report, we issued 8,571,884 unregistered shares of our common stock upon the exercise of various warrants. The shares issued were exempt from registration under the Securities Act of 1933 pursuant to Section 3(a)(9) thereof.

The following table provides information with respect to purchases we made of shares of our common stock during the quarter ended March 31, 2012.


Period	(a) Total Number of Shares (or Units) Purchased		(b) Average Price Paid per Share (or Unit) (1)		(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (2)		(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
Jan. 1, 2012 to Jan. 31, 2012		228,926	$	1.42		228,926	$	4,023,926
Feb. 1, 2012 to Feb. 29, 2012		0		—		—	$	4,023,926
Mar. 1, 2012 to Mar. 31, 2012		0		—		—	$	4,023,926

Total		228,926	$	1.42		228,926

(1)	Average price paid per share of common stock repurchased is the execution price, including commissions paid to brokers.

(2)

On December 19, 2011, we announced that we entered into a pre-arranged stock repurchase plan that operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934. We are authorized to purchase an aggregate amount of up to $5 million of shares of our common stock under this plan. The repurchases made under this plan apply against the stock repurchase authorization we announced on September 6, 2011.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

See the exhibit index immediately following the signature page of this report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


				LIFEVANTAGE CORPORATION

Date: May 15, 2012				/s/ Douglas C. Robinson
				Douglas C. Robinson President and Chief Executive Officer (Principal Executive Officer)

Date: May 15, 2012				/s/ Carrie E. McQueen
				Carrie E. McQueen Chief Financial Officer (Principal Financial Officer)

Exhibit Index


Exhibit		Description

10.1#		2010 Long-Term Incentive Plan, as amended on January 10, 2012 (1)

10.2#		Amendment to Employment Agreement dated March 23, 2012 between LifeVantage Corporation and Douglas C. Robinson (2)

31.1		Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a)

31.2		Certification of principal financial officer pursuant to Rule 13a-14(a)/15d-14(a)

32.1*		Certification of principal executive officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*		Certification of principal financial officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101**		The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at March 31, 2012 and June 30, 2011; (ii) Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income for the three month periods ended March 31, 2012 and 2010; (iii) Unaudited Condensed Consolidated Statement of Stockholders’ Deficit for the nine months ended March 31, 2012; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the nine month periods ended March 31, 2012 and 2010; and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text.

#	Management contract or compensatory plan.

(1)	Filed as an exhibit to the registrant’s current report on Form 8-K filed on January 17, 2012, and incorporated herein by reference

(2)	Filed as an exhibit to the registrant’s current report on Form 8-K filed on March 27, 2012, and incorporated herein by reference

This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing

Users of this data are advised that pursuant to Rule 406T of Regulation S-T, this XBRL information is being furnished and not filed herewith for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and Sections 11 or 12 of the Securities Act of 1933, as amended, and is not to be incorporated by reference into any filing, or part of any registration statement or prospectus, of LifeVantage Corporation, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

EX-31.1 2 d346854dex311.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER Certification of Principal Executive Officer

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Douglas C. Robinson, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Lifevantage Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2012

/s/ Douglas C. Robinson

Douglas C. Robinson

President and Chief Executive Officer

(Principal Executive Officer)

EX-31.2 3 d346854dex312.htm CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER Certification of Principal Financial Officer

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Carrie E. McQueen, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Lifevantage Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2012

/s/ Carrie E. McQueen

Carrie E. McQueen

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 d346854dex321.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER Certification of Principal Executive Officer

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of this quarterly report on Form 10-Q of Lifevantage Corporation (the “Company”) for the period ended March 31, 2012, with the Securities and Exchange Commission on the date hereof (the “report”), I, Douglas C. Robinson, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the report or as a separate disclosure document.

Date: May 15, 2012

/s/ Douglas C. Robinson

Douglas C. Robinson

President and Chief Executive Officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 d346854dex322.htm CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER Certification of Principal Financial Officer

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of this quarterly report on Form 10-Q of Lifevantage Corporation (the “Company”) for the period ended March 31, 2012, with the Securities and Exchange Commission on the date hereof (the “report”), I, Carrie E. McQueen, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1)	The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)	The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the report or as a separate disclosure document.

Date: May 15, 2012

/s/ Carrie E. McQueen

Carrie E. McQueen

Chief Financial Officer

(Principal Financial Officer)

EX-101.INS 6 lfvn-20120331.xml XBRL INSTANCE DOCUMENT 0000849146 2012-05-08 0000849146 2012-03-31 0000849146 2011-06-30 0000849146 2012-01-01 2012-03-31 0000849146 2011-01-01 2011-03-31 0000849146 2011-07-01 2012-03-31 0000849146 2010-07-01 2011-03-31 0000849146 us-gaap:CommonStockMember 2011-06-30 0000849146 us-gaap:AdditionalPaidInCapitalMember 2011-06-30 0000849146 us-gaap:RetainedEarningsMember 2011-06-30 0000849146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-06-30 0000849146 us-gaap:AdditionalPaidInCapitalMember 2011-07-01 2012-03-31 0000849146 us-gaap:CommonStockMember 2011-07-01 2012-03-31 0000849146 us-gaap:RetainedEarningsMember 2011-07-01 2012-03-31 0000849146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-07-01 2012-03-31 0000849146 us-gaap:CommonStockMember 2012-03-31 0000849146 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0000849146 us-gaap:RetainedEarningsMember 2012-03-31 0000849146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-03-31 0000849146 2010-06-30 0000849146 2011-03-31 iso4217:USD xbrli:shares xbrli:shares iso4217:USD Lifevantage Corp 0000849146 --06-30 Smaller Reporting Company 10-Q false 2012-03-31 Q3 2012 110067349

16896369

6370974

350000

817158

941802

6980520

2124663

2237494

1948426 487812

28879967

10275251

1766609

227811

1912399

1963277

474506

342173

32173

33375654

12498512

799210

4433803

1999969

764894 435135

1835480

782852

3643826

1423370

90691

69893

0 433984

7435883

10768694

13380296

76430

21017

19905401

10845124

33306714

0.001

50000000

109898

98795

0.001

250000000

109219361

98794499

109219361

98794499

104260897

67606293

-81792667

-88453607

-47598

-59683

22530530

-20808202

33375654

12498512

36211615

9975224

81578972

23878662

4988548

1581866

11624980

3793535

31223067

8393358

69953992

20085127

19676246

5350388

44096845

12781834

4616165

2081108

10491795

5084270

378098

115515

924450

315025

146063

54084

322740

157984

24816572

7601095

55835830

18339113

6406495

792263

14118162

1746014

-21310

468900

-8570

2477805

-10686945

-10090924

-6740525

-2777953

-10665635

-10559824

-6731955

-5255758

-4259140

-9767561

7386207

-3509744

586653

-250806

95000

-4845793

-9767561

7637013

-3604744

-0.05

-0.13

0.08

-0.05

-0.13

0.07

-0.05

103016170

73181511

100450870

69281640

103016170

73181511

115232578

69281640

-80278

-17359

12085

-24825

-80278

-17359

12085

-24825

-4926071

-9784920

7649098

-3629569

98794499

98795

67606293

-88453607

-59683

880891

10954535 10954 19295791 19306745

149253

149

-149

678926

976073

16478071

12085

7637013

109219361

109898

104260897

-81792667

-47598

748212

397183

132679

53597

-2712000

583738

1644158

-124644

402390

4855857

977880

1770614

266637

61440

940

-799210

104101

6036677

1977148

11666249

2445151

350000

75000

49389

24208

1743718

64743

-1443107

-13951

-433984

2782

-309565

976073

50000 1393442

290168

50000

12085

-24825

10525395

2456375

1637676

4094051

2329365 3804936

276625

2280000

56000

Note 1 — Organization and Basis of Presentation: The condensed consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the management of LifeVantage Corporation (“LifeVantage” or the “Company”), these interim financial statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair presentation of our financial position as of March 31, 2012, and the results of operations for the three and nine month periods ended March 31, 2012 and 2011 and the cash flows for the nine month periods ended March 31, 2012 and 2011. Interim results are not necessarily indicative of results for a full year or for any future period. The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in our audited financial statements and notes for the fiscal year ended June 30, 2011 pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June 30, 2011, and included in the Annual report on Form 10-K on file with the SEC.

Note 2 — Summary of Significant Accounting Policies: Consolidation The accompanying financial statements include the accounts of LifeVantage Corporation and our wholly-owned subsidiaries Lifeline Nutraceuticals Corporation (“LNC”), LifeVantage de México, S. de R.L. de C.V. (Limited Liability Company), Importadora LifeVantage, S. de R.L. de C.V. (Limited Liability Company), and Servicios Administrativos para la Importación de Productos Body & Skin, S.C. All inter-company accounts and transactions between the entities have been eliminated in consolidation. Translation of Foreign Currency Statements We translate the financial statements of our foreign entities by using the current exchange rate. For assets and liabilities, the exchange rate at the balance sheet date is used. For any investment in subsidiaries and retained earnings, the historical exchange rate is used. For revenue, expenses, gains, and losses, an appropriately weighted average exchange rate for the period is used. Use of Estimates Management has made a number of estimates and assumptions relating to the reporting of revenues, expenses, assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements. Actual results could differ from those estimates. Fair Value Measurements Fair value measurement requirements are embodied in certain accounting standards applied in the preparation of our financial statements. Significant fair value measurements include our embedded derivative liabilities. See Note 4 — Stockholders Equity for disclosures related to our common stock and warrant financing arrangements. The fair value hierarchy is defined below: Fair value hierarchy: (1) Level 1 inputs are quoted prices in active markets for identical assets and liabilities. (2) Level 2 inputs are inputs which include quoted prices for similar assets and liabilities in active markets and inputs that are observable for the assets or liabilities, either directly or indirectly, for substantially the full term of the financial instrument. (3) Level 3 inputs are unobservable inputs and significant to the fair value measurement.   The financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. There were no financial instrument measured at fair value at March 31, 2012. The summary of fair values of financial instruments is as follows at June 30, 2011:   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="56%"> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> </tr> <tr> <td valign="bottom" nowrap="nowrap">Instrument:</td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">Fair value</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">Carrying Value</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">Level</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">Valuation Methodology</td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Investments </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">350,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">350,000</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">Market price</td> </tr> <tr> <td valign="bottom"> Derivative liabilities </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">27,341,284</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">27,341,284</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="top">Black-Scholes Dilution adjusted</td> </tr>  </table> The following represents a reconciliation of the changes in fair value of financial instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended March 31, 2012 and the year ended June 30, 2011:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="70%"> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="5%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">June 30, 2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Beginning balance: Derivative liabilities </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">27,341,284</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,567,450</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Total (gains) losses </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,740,525</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">48,454,271</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Reclassification of liability to equity </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(16,478,071</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Purchases, sales, issuances and settlements, net </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(17,603,738</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(39,680,437</td> <td nowrap="nowrap" valign="bottom">) </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Ending balance: Derivative liabilities </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—  </td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">27,341,284</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> Warrants issued with convertible debentures that we issued from November 2009 through February 2010 were amended effective December 29, 2011. The amendment removed certain price-based anti-dilution provisions which had resulted in the warrants being treated as liabilities and as a result the fair value of the warrants was reclassified to equity as of December 29, 2011. Warrants issued in association with a common stock financing in March and April of 2009 and which had expirations of March and April 2012 have all been exercised as of March 31, 2012 and as a result there is no derivative liability as of that date. Cash and Cash Equivalents We consider only our monetary liquid assets with original maturities of three months or less as cash and cash equivalents. Accounts Receivable Accounts receivable at March 31, 2012 consist primarily of credit card receivables including a holdback by the credit card processor. The holdback balance at March 31, 2012 was $500,000. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its direct and independent distributor sales as of March 31, 2012 is not necessary. No bad debt expense has been recorded for the three and nine months ended March 31, 2012 or the year ended June 30, 2011. Investments In 2008 we invested in auction rate preferred securities of closed-end funds (“ARPS”) to maximize interest income. As of March 31, 2012 all these investments have been sold.   Inventory Inventory is stated at the lower of cost or market value. Cost is determined using the first-in, first-out method. We have capitalized payments to our contract product manufacturer for the acquisition of raw materials and commencement of the manufacturing, bottling and labeling of our product. As of March 31, 2012 and June 30, 2011, inventory consisted of:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="74%"> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="4%"> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">March 31, 2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">June 30, 2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Finished goods </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,584,305</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">736,103</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Raw materials </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,396,215</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,388,560</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Total inventory </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,980,520</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,124,663</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> Revenue Recognition We ship the majority of our product directly to the consumer via UPS and receive substantially all payment for these sales in the form of credit card charges. Revenue from direct product sales to customers is recognized upon passage of title and risk of loss to customers when product is shipped from the fulfillment facility. Sales revenue and estimated returns are recorded when product is shipped. Our return policy is to provide a 30-day money back guarantee on orders placed by customers. After 30 days, we do not issue refunds to direct sales customers for returned product. In the network marketing sales channel, we allow terminating distributors to return unopened unexpired product that they have purchased within the prior twelve months, subject to certain consumption limitations. To date, returns from terminating distributors have been negligible. Our return rate for sales directly to consumers and sales through our network channel are based on our historical experience which we analyze on a regular basis. As of March 31, 2012 and June 30, 2011, our reserve balance for returns and allowances was $764,894 and $435,135, respectively. Income per share Basic income or loss per share is computed by dividing the net income or loss by the weighted average number of common shares outstanding during the period. Diluted earnings per common share are computed by dividing net income by the weighted average common shares and potentially dilutive common share equivalents. For the three month period ended March 31, 2012 the effects of approximately 25 million common shares issuable upon exercise of warrants issued in our private placement offerings and options granted through our 2007 and 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive. For the nine month period ended March 31, 2012 the effects of approximately 120,000 common shares, respectively, issuable upon exercise of options granted through our 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive. For the three and nine month periods ended March 31, 2011 the effects of approximately 62 million common shares, respectively, issuable upon exercise of warrants issued in our private placement offerings, compensation based warrants issued and options granted through our 2007 and 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive. Segment Information Our operations are aggregated into a single reportable operating segment based upon similar economic and operating characteristics as well as similar markets. Our operations are also subject to similar regulatory environments. We conduct our operations in the Americas which includes the U.S., Canada and Mexico and in Japan. Substantially all long-lived assets are located in the U.S. Revenues by geographic area are as follows:   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center">  <tr> <td width="53%"> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">Three months ended March 31,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">Nine months ended March 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000">2011</td> <td valign="bottom"> </td> </tr>   <tr bgcolor="#cceeff"> <td valign="top"> Americas operations </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">25,745,524</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,150,636</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">59,612,464</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,223,278</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr> <td valign="top"> Japan operations </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,466,091</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,824,588</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,966,508</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,655,384</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> Total revenues </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">36,211,615</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,975,224</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">81,578,972</td> <td nowrap="nowrap" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,878,662</td> <td nowrap="nowrap" valign="bottom"> </td> </tr> <tr style="font-size:1px"> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr>  </table> Research and Development Costs We expense all costs related to research and development activities as incurred. Research and development expenses for the nine month periods ended March 31, 2012 and 2011 were $924,450 and $315,025, respectively. Shipping and Handling Shipping and handling costs associated with inbound freight and freight out to customers, including independent distributors, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.   Stock-Based Compensation In certain circumstances, we issued common stock for invoiced services and in other similar situations to pay contractors and vendors. Payments in equity instruments to non-employees for goods or services are accounted for using the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. Derivative Financial Instruments We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. However, we have entered into certain other financial instruments and contracts, such as freestanding warrants and embedded conversion features on convertible debt instruments that are not afforded equity classification. These instruments are required to be carried as derivative liabilities, at fair value, in our consolidated financial statements. Derivative financial instruments consist of financial instruments or other contracts that contain a notional amount and one or more underlying variables (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. We estimate fair values of derivative financial instruments using various techniques that are considered to be consistent with the objective measurement of fair values. In selecting the appropriate technique, we consider, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as freestanding warrants, we generally use the Black Scholes Merton option valuation technique, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, and risk free rates) necessary to fairly value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock. Since derivative financial instruments are initially and subsequently carried at fair values, our income or loss will reflect the volatility in changes to these estimates and assumptions. As of March 31, 2012 all financial instruments subject to fair value treatment had been exercised or amended and we have no derivative instruments subject to fair value liability treatment. Income Taxes Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items which are recorded in the interim period. The provision for income taxes for the three months ended March 31, 2012 and 2011 differs from the amount that would be provided by applying the statutory U.S. federal income tax rate of 34% to pre-tax income primarily because of state income taxes, estimated permanent differences and change in valuation allowance. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in various jurisdictions, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known or as the tax environment changes. As of March 31, 2012 we have recognized a net income tax benefit of $250,806 which is our estimated federal and state income tax liability for the nine months ended March 31, 2012 combined with the income tax benefit resulting from the reduction in the valuation allowance in the previous quarter. Realization of our deferred tax asset is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain. In December 2011, we determined it was more likely than not that the deferred tax asset would be realized and as a result we released the valuation allowance we had established resulting in a net benefit of $2,802,000 which represents the benefit expected to be realized in future years. As of March 31, 2012 the net deferred tax benefit was $2,712,000. Effective January 1, 2009, we account for any uncertainty in income taxes by recognizing the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits recognized in the financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. The application of income tax law is inherently complex. As such, we are required to make subjective assumptions and judgments regarding income tax exposures. The result of the reassessment of our tax positions did not have an impact on the consolidated financial statements. Concentration of Credit Risk We disclose significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments. At March 31, 2012, we had $11,249,095 in cash accounts at one financial institution, approximately $897,154 in foreign bank accounts and $5,000,120 in an investment management account at another financial institution. As of March 31, 2012 and June 30, 2011 the Company’s cash balances exceeded federally insured limits. Effect of New Accounting Pronouncements We have reviewed recently issued, but not yet effective, accounting pronouncements and do not believe any such pronouncements will have a material impact on our financial statements.

Note 3 — Line of Credit We established a line of credit to borrow up to 80% of our investments in certain marketable securities. The line was collateralized by the proceeds of the repurchase of the marketable securities. The line was paid in full in January 2012, in conjunction with the settlement of the marketable securities and is now closed.

Note 4 — Stockholders’ Equity During the three and nine months ended March 31, 2012 we issued 8,571,884 and 9,405,035 shares of common stock, respectively, upon the exercise of warrants. During the three and nine months ended March 31, 2012 we issued 888,500 and 1,549,500 shares of common stock, respectively, upon the exercise of stock options. During the three and nine month periods ended March 31, 2012 we repurchased 228,926 and 678,926 shares of our common stock, respectively, at a total cost of $325,000 and $976,073, respectively. The cost of the shares is classified against our accumulated deficit as of March 31, 2012 as we have effectively retired these shares. During the three and nine months ended March 31, 2012 we issued 149,253 shares of restricted stock. The restricted stock vests in equal annual installments over four years Our Articles of Incorporation authorize the issuance of preferred shares. However, as of March 31, 2012, none have been issued nor have any rights or preferences been assigned to the preferred shares by our Board of Directors. In December 2011, certain outstanding warrants were amended removing price-based anti-dilution protection in exchange for a one month increase in the life of the warrants. As a result of this amendment, the warrants became classified as equity rather than a liability. In conjunction with the amendment, we marked the warrants to fair value, including the inducement, as of the date of the amendment, and then reclassified the liability of $16,478,071 to additional paid in capital.

Note 5 — Stock-based Compensation We adopted and the shareholders approved the 2007 Long-Term Incentive Plan (the “2007 Plan”), effective November 21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 10,000,000 shares of our common stock can be issued under the 2007 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2007 Plan and are outstanding to employees, officers, directors, independent distributors and Scientific Advisory Board (“SAB”) members at prices between $0.21 and $0.76 per share, vesting over one- to three-year periods. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2007 Plan upon expiration of the award. As of March 31, 2012, awards for the purchase of an aggregate of 6,997,600 shares of our common stock are outstanding under the 2007 Plan. We adopted and the shareholders approved the 2010 Long-Term Incentive Plan (the “2010 Plan”), effective September 27, 2010, to provide incentives to eligible employees, directors and consultants. As of March 31, 2012 a maximum of 6,900,000 shares of our common stock were available for issuance under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to employees, officers and directors at prices between $0.63 and $1.75 per share, vesting over ten month- to four-year periods. As of March 31, 2012, awards for the purchase of an aggregate of 3,874,003 shares of our common stock are outstanding under the 2010 Plan. At our annual meeting of shareholders in January 2012 our shareholders approved a 3,400,000 share increase in the number of shares available for issuance under the 2010 Plan, increasing the total number of shares reserved from 3,500,000 to 6,900,000 shares. Payments in equity instruments for goods or services are accounted for under the guidance of share based payments, which require use of the fair value method. We have adjusted the expense for the anticipated forfeitures. Compensation based options and restricted stock totaling 1,822,003 and 1,935,003 shares were granted for the three and nine month periods ended March 31, 2012, respectively. Compensation based options totaling 44,000 and 102,000 shares were granted for the three and nine month periods ended March 31, 2011, respectively. For the three and nine months ended March 31, 2012, stock based compensation of $307,840 and $880,891, respectively, was reflected as an increase to additional paid in capital. Of the stock based compensation for the three and nine months ended March 31, 2012, $307,840 and $748,212, respectively, was employee related and none and $132,679, respectively, was non-employee related. For the three and nine months ended March 31, 2011, stock based compensation of $288,665 and $450,780, respectively, was reflected as an increase to additional paid in capital. Of the stock based compensation for the three and nine months ended March 31, 2011, $264,666 and $397,183, respectively, was employee related and $23,999 and $53,597, respectively, was non-employee related. Compensation expense was calculated using the fair value method during the three and nine month periods ended March 31, 2012 and 2011 using the Black-Scholes option pricing model. The following assumptions were used for options and warrants granted during the nine month periods ended March 31, 2012 and 2011:   <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%"> </td> <td width="4%" valign="top" align="left">1.</td> <td align="left" valign="top">risk-free interest rates of between 0.93 and 1.55 percent for the nine months ended March 31, 2012 and between 1.33 and 2.64 percent for the nine months ended March 31, 2011; </td> </tr> </table>   <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%"> </td> <td width="4%" valign="top" align="left">2.</td> <td align="left" valign="top">dividend yield of -0- percent; </td> </tr> </table>   <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%"> </td> <td width="4%" valign="top" align="left">3.</td> <td align="left" valign="top">expected life of 3 to 6 years; and </td> </tr> </table>   <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%"> </td> <td width="4%" valign="top" align="left">4.</td> <td align="left" valign="top">a volatility factor of the expected market price of our common stock of between 127 and 137 percent for the nine months ended March 31, 2012 between 125 and 129 percent for the nine months ended March 31, 2011. </td> </tr> </table>

EX-101.SCH 7 lfvn-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 01 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 011 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 02 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 03 - Statement - Condensed Consolidated Statements of Stockholders' Equity and Comprehensive Income (Unaudited) link:presentationLink link:definitionLink link:calculationLink 04 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 06001 - Disclosure - Organization and Basis of Presentation: link:presentationLink link:definitionLink link:calculationLink 06002 - Disclosure - Summary of Significant Accounting Policies: link:presentationLink link:definitionLink link:calculationLink 06003 - Disclosure - Line of Credit link:presentationLink link:definitionLink link:calculationLink 06004 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 06005 - Disclosure - Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 lfvn-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 lfvn-20120331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 lfvn-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Statement, Equity Components [Axis] Equity Component [Domain] ASSETS Assets [Abstract] Current assets Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Marketable securities, available for sale Available-for-sale Securities, Debt Securities, Current Accounts receivable, net Accounts Receivable, Net, Current Inventory Inventory, Net Current deferred income tax asset Deferred Tax Assets, Net, Current Prepaid Expenses and Deposits Prepaid expenses and deposits Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets and probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Prepaid expenses and deposits Total current assets Assets, Current, Total Total current assets Long-term assets Assets, Noncurrent [Abstract] Property and equipment, net Property, Plant and Equipment, Net Intangible assets, net Finite-Lived Intangible Assets, Net Long-term deferred income tax asset Deferred Tax Assets, Net, Noncurrent Deposits Deposits Assets, Noncurrent Deposits TOTAL ASSETS Assets, Total TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities and Equity [Abstract] Current liabilities Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Commissions payable Commissions Payable to Broker-Dealers and Clearing Organizations Reserve for Sales Returns Reserve for sales returns Reserve for the amount of products sold that the entity expects to be returned by the purchaser. Accrued bonuses Accrued Bonuses, Current Other accrued expenses Other Accrued Liabilities, Current Other current liabilities Other Liabilities, Current Revolving Line of Credit and Accrued Interest Revolving line of credit and accrued interest Carrying amount at the balance sheet date of borrowings from a creditor other than a bank, not elsewhere specified in the taxonomy, with a maturity within one year (or within one operating cycle if longer) from the date of borrowing. Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Short-term derivative liabilities Derivative Liabilities, Current Short-term derivative liabilities Total current liabilities Liabilities, Current, Total Total current liabilities Long-term liabilities Liabilities, Noncurrent [Abstract] Other long-term liabilities Other Liabilities, Noncurrent Derivative liabilities Derivative Liabilities, Noncurrent Derivative liabilities Total liabilities Liabilities, Total Total liabilities Commitments and contingencies Commitments and Contingencies Stockholders' equity (deficit) Stockholders' Equity Attributable to Parent [Abstract] Preferred stock - par value $0.001 per share, 50,000,000 shares authorized, no shares issued or outstanding Preferred Stock, Value, Issued Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock - par value $0.001 per share, 250,000,000 shares authorized and 109,219,361 and 98,794,499 issued and outstanding as of March 31, 2012 and June 30, 2011, respectively Common Stock, Value, Issued Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Total stockholders' equity (deficit) Stockholders' Equity Attributable to Parent, Total Total stockholders' equity (deficit) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities and Equity, Total TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Sales, net Revenue, Net Cost of sales Cost of Goods and Services Sold Cost of sales Gross profit Gross Profit Gross profit Operating expenses: Operating Expenses [Abstract] Sales and marketing Selling and Marketing Expense General and administrative General and Administrative Expense Research and development Research and Development Expense Depreciation and amortization Depreciation, Depletion and Amortization Depreciation and amortization Total operating expenses Operating Expenses, Total Total operating expenses Operating income Operating Income (Loss) Operating income Other income (expense): Nonoperating Income (Expense) [Abstract] Interest income (expense) Interest Expense Interest income (expense) Change in fair value of derivative liabilities Gain (Loss) on Derivative Instruments, Net, Pretax Change in fair value of derivative liabilities Total other income (loss) Nonoperating Income (Expense), Total Total other income (loss) Net income (loss) before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Net income (loss) before income taxes Income tax (expense) benefit Income Tax Expense (Benefit) Income tax (expense) benefit Net income (loss) Net Income (Loss) Attributable to Parent Net income (loss) Net income (loss) per share, basic Earnings Per Share, Basic Net income (loss) per share, diluted Earnings Per Share, Diluted Weighted average shares, basic Weighted Average Number of Shares Outstanding, Basic Weighted average shares, diluted Weighted Average Number of Shares Outstanding, Diluted Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss) Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) Statement [Table] Statement [Line Items] Common Stock Balance, shares Balance Balance Additional Paid In Capital Accumulated Deficit Accumulated Other Comprehensive Income/(Loss) Options/Warrants issued for services Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock Issued During Period Shares Stock Options and Warrants Exercised Exercise of options and warrants, shares Exercise of options and warrants, shares Stock Issued During Period Value Stock Options and Warrants Exercised Exercise of options and warrants Exercise of options and warrants Issuance of restricted stock, shares Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of restricted stock Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Repurchase of company stock, shares Stock Repurchased During Period, Shares Repurchase of company stock, shares Repurchase of company stock Stock Repurchased During Period, Value Repurchase of company stock Reclassification of liability warrants Adjustments to Additional Paid in Capital, Warrant Issued Balance, shares Balance Cash Flows from Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Stock based compensation to employees Share-based Compensation Stock based compensation to non-employees Share-based Goods and Nonemployee Services Transaction, Expense Deferred income tax benefit Deferred Income Tax Expense (Benefit) Amortization of deferred offering costs Other Amortization of Deferred Charges Non-cash interest expense Paid-in-Kind Interest Change in fair value of derivative liabilities Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Decrease (increase) in accounts receivable Increase (Decrease) in Accounts Receivable Decrease (increase) in accounts receivable (Increase) in inventory Increase (Decrease) in Inventories (Increase) in inventory (Increase) in prepaid expenses and deposits Increase (Decrease) in Prepaid Expense (Increase) in prepaid expenses and deposits Increase in other liabilities Increase (Decrease) in Other Operating Liabilities (Decrease) increase in accounts payable Increase (Decrease) in Accounts Payable Increase in accrued expenses Increase (Decrease) in Accrued Liabilities Increase in accrued expenses Net Cash Provided by Operating Activities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by Operating Activities Cash Flows from Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Redemption of marketable securities Proceeds from Sale of Available-for-sale Securities, Debt Purchase of intangible assets Payments to Acquire Intangible Assets Purchase of intangible assets Purchase of equipment Payments to Acquire Property, Plant, and Equipment Purchase of equipment Net Cash Used in Investing Activities Net Cash Provided by (Used in) Investing Activities Net Cash Used in Investing Activities Cash Flows from Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Net Payments on Proceeds from Revolving Line of Credit and Accrued Interest Net payments proceeds from revolving line of credit and accrued interest Net payments proceeds from revolving line of credit and accrued interest Principal payments under capital lease obligation Repayments of Long-term Capital Lease Obligations Principal payments under capital lease obligation Excess tax benefits from stock-based compensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Excess tax benefits from stock-based compensation Repurchase of company stock Payments for Repurchase of Common Stock Repurchase of company stock Issuance of Common Stock and Warrants Issuance of common stock and warrants Issuance of common stock and warrants Proceeds from Exercise of Options and Warrants Exercise of options and warrants Exercise of options and warrants Net Cash Provided by Financing Activities Net Cash Provided by (Used in) Financing Activities Net Cash Provided by Financing Activities Foreign Currency Effect on Cash Effect of Exchange Rate on Cash and Cash Equivalents Foreign Currency Effect on Cash Increase in Cash and Cash Equivalents: Cash and Cash Equivalents, Period Increase (Decrease) Increase in Cash and Cash Equivalents: Cash and Cash Equivalents - beginning of period Cash and Cash Equivalents - end of period Non Cash Investing and Financing Activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Conversion of Debt to Common Stock Conversion of debt to common stock Conversion of long-term debt to common stock Conversion of Derivative to Common Stock Conversion of derivative to common stock Conversion of derivative to common stock SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Supplemental Cash Flow Information [Abstract] Cash paid for interest expense Interest Paid Cash paid for income taxes Income Taxes Paid Organization and Basis of Presentation: Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Basis of Presentation: [Abstract] Organization and Basis of Presentation: [Abstract] Summary of Significant Accounting Policies: Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies: [Abstract] Summary of Significant Accounting Policies: [Abstract] Line of Credit [Text Block] Line of Credit Line of Credit Line of Credit [Abstract] Line of Credit [Abstract] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity [Abstract] Stockholders' Equity [Abstract] Stock-based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-based Compensation [Abstract] Stock-based Compensation [Abstract] Amendment Flag Current Fiscal Year End Date Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name Document Fiscal Period Focus Document Fiscal Year Focus Condensed Consolidated Balance Sheets [Abstract] Condensed Consolidated Statements of Operations [Abstract] Condensed Consolidated Statements of Stockholders' Equity and comprehensive Income [Abstract] Condensed Consolidated Statements of Cash Flows [Abstract] EX-101.PRE 11 lfvn-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT

Line of Credit

9 Months Ended

Mar. 31, 2012

Line of Credit [Abstract]

Line of Credit

Note 3 — Line of Credit

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\X,34V,#AA9E\W-35C7S0R8S5?83%B,5\X8V-E M-C8U,6$S9F0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=OF%T:6]N7V%N9%]"87-I#I%>&-E;%=O M5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I%>&-E;%=O M#I7;W)K M#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X M,34V,#AA9E\W-35C7S0R8S5?83%B,5\X8V-E-C8U,6$S9F0-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.#$U-C`X869?-S4U8U\T,F,U7V$Q8C%? M.&-C938V-3%A,V9D+U=O'0O:'1M;#L@8VAA2!);F9O2`P."P@,C`Q,CQB'0^3&EF979A;G1A9V4@0V]R<#QS<&%N/CPO M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO'0^43,\2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^4VUA;&QE M3QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"!A M'!E;G-E'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2`H9&5F:6-I="D\ M+W-TF5D(&%N9"`Q,#DL,C$Y+#,V,2!A;F0@.3@L-SDT+#0Y.2!I2`H9&5F:6-I="D\+W1D/@T*("`@ M("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3`L,#`P+#`P,#QS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E'!E;G-E*3H\+W-T'!E;G-E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S"`H97AP96YS92D@8F5N969I=#PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S#H\+W-T2!T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&5R8VES92!O9B!O<'1I;VYS(&%N9"!W87)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M65E"!B96YE M9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!/<&5R871I;F<@06-T:79I=&EE"!B96YE9FET'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&5R8VES92!O9B!O<'1I M;VYS(&%N9"!W87)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA MF%T:6]N(&%N9"!"87-IF%T:6]N(&%N9"!"87-IF%T:6]N(&%N9"!"87-IF%T:6]N0V]N&)R;"QN&)R;"QN>"`M+3X-"B`@(#QF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/CPO9F]N=#X-"B`@(#QF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/@T*("`@/"]F;VYT/@T*("`@/'`@#MM87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!U6QE/3-$)VUA#MM87)G:6XM8F]T=&]M.C!P>#L@ M=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X M,34V,#AA9E\W-35C7S0R8S5?83%B,5\X8V-E-C8U,6$S9F0-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.#$U-C`X869?-S4U8U\T,F,U7V$Q8C%? M.&-C938V-3%A,V9D+U=O'0O:'1M;#L@8VAA2!O M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S.CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/"$M+41/0U194$4@:'1M;"!054),24,@ M(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E M(#(@+2!U#MM87)G M:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/CQB/DYO=&4@,B`F(S@R,3([(%-U;6UA M6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE/3-$)VUA2!#;VUP86YY*2P@86YD(%-E2!A8V-O M=6YT6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@2!U2!I;G9E2!W M96EG:'1E9"!A=F5R86=E(&5X8VAA;F=E(')A=&4@9F]R('1H92!P97)I;V0@ M:7,@=7-E9"X-"B`@(#PO9F]N=#X\+W`^#0H@("`\<"!S='EL93TS1&UA#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/CQB/E5S92!O M9B!%#MM87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z M-"4G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$;6%R9VEN+71O<#HQ.'!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@#MM87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD96YT.C0E)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/D9A:7(@=F%L=64@:&EE'0M:6YD96YT.C0E)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/@T* M("`@*#$I($QE=F5L(#$@:6YP=71S(&%R92!Q=6]T960@<')I8V5S(&EN(&%C M=&EV92!M87)K971S(&9O6QE/3-$)VUA2!T:&4@9G5L;"!T97)M(&]F('1H92!F:6YA;F-I86P@:6YS=')U M;65N="X@/"]F;VYT/CPO<#X-"B`@(#QP('-T>6QE/3-$)VUA6QE/3-$9F]N="US:7IE.C%P M>#MM87)G:6XM=&]P.C$R<'@[;6%R9VEN+6)O='1O;3HP<'@^)B,Q-C`[/"]P M/@T*("`@/'`@2!I2!I;G!U="!T:&%T(&ES('-I9VYI9FEC86YT('1O('1H92!F86ER M('9A;'5E(&UE87-U6QE/3-$)VUA#MM87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ MF4Z M,3)P>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\ M+W`^#0H@("`\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#DR)2!B;W)D97(],T0P('-T>6QE/3-$)V)O3IT:6UEF4],T0Q/CQB/DEN"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0Q/CQB/D-AF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@2`M+3X-"B`@(#QT M3IT:6UEF4],T0R/DEN=F5S=&UE;G1S/"]F;VYT/CPO<#X-"B`@ M(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT M:6UEF4],T0R/C,U,"PP,#`\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/C(W+#,T,2PR.#0\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1T;W`^/&9O;G0@6QE/3-$9F]N="US:7IE.C$R<'@[;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HP<'@^)B,Q-C`[/"]P/@T*("`@/'1A8FQE(&-E;&QS M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0W-B4@8F]R9&5R M/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P'0M M86QI9VXZ(&QE9G0G(&%L:6=N/3-$8V5N=&5R/@T*("`@/"$M+2!"96=I;B!4 M86)L92!(96%D("TM/@T*("`@/'1R/B`-"B`@(#QT9"!W:61T:#TS1#F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@2`M+3X-"B`@ M(#QT3IT:6UE MF4],T0R/D)E9VEN;FEN9R!B86QA;F-E.B!$97)I M=F%T:79E(&QI86)I;&ET:65S/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O M;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C(W+#,T,2PR.#0\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M;F]W3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/C0X+#0U-"PR-S$\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/B8C.#(Q,CLF(S$V,#LF(S$V,#L\+V9O;G0^/"]T M9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/B@S.2PV.#`L-#,W/"]F;VYT M/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V)O6QE/3-$)V)O3IT:6UEF4] M,T0R/D5N9&EN9R!B86QA;F-E.B!$97)I=F%T:79E(&QI86)I;&ET:65S/"]F M;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C.#(Q,CLF M(S$V,#LF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE M/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@"!D;W5B;&4@(S`P M,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*("`@/'`@2`M+3X- M"B`@(#PO=&%B;&4^#0H@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.C$R<'@[ M;6%R9VEN+6)O='1O;3HP<'@[('1E>'0M:6YD96YT.C0E)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E=A M2!A M#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CQB/D-A M6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@2!O=7(@ M;6]N971A6QE/3-$;6%R9VEN M+71O<#HQ.'!X.VUA6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$ M)VUA28C.#(Q-SMS('9E65A6QE/3-$)VUA&EM:7IE(&EN=&5R M97-T(&EN8V]M92X@07,@;V8-"B`@($UAF4Z,7!X.VUA#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\<"!S='EL93TS M1&UA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD96YT.C0E M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/DEN=F5N=&]R>2!IF5D#0H@("!P87EM96YTF4Z,3)P>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T M=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#6QE M/3-$)V)OF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P M,#`P)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/DUA3IT:6UEF4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^(`T*("`@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L M3IT M:6UEF4],T0Q/CQB/C(P,3$\+V(^/"]F;VYT/CPO M=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(S$V,#L\+V9O;G0^/"]T9#X-"B`@(#PO='(^#0H@("`\(2TM($5N9"!486)L M92!(96%D("TM/@T*("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@ M/'1R(&)G8V]L;W(],T0C8V-E969F/B`-"B`@(#QT9"!V86QI9VX],T1T;W`^ M#0H@("`\<"!S='EL93TS1"=M87)G:6XM;&5F=#HQ+C`P96T[('1E>'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E)A=R!M871EF4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$L,S@X+#4V,#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O3IT:6UEF4],T0R/E1O=&%L(&EN=F5N=&]R>3PO M9F]N=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3IT:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/@T*("`@/"]TF4Z,7!X/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`@(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$;6%R9VEN+71O<#HQ.'!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)VUA6UE;G0@9F]R('1H97-E('-A;&5S(&EN('1H92!F;W)M(&]F M(&-R961I="!C87)D(&-H87)G97,N(%)E=F5N=64@9G)O;2!D:7)E8W0@<')O M9'5C="!S86QE7IE(&]N(&$@2X@/"]F;VYT/CPO<#X-"B`@(#QP('-T>6QE/3-$;6%R9VEN+71O<#HQ M.'!X.VUA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)VUA2!T:&4@=V5I9VAT960@879E&EM871E;'D@,3(P+#`P,"!C;VUM;VX@3IT:6UEF4],T0R/CQB/E-E9VUE;G0@26YF;W)M871I;VX@/"]B/CPO9F]N M=#X\+W`^#0H@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.C9P>#MM87)G:6XM M8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!A;&P@;&]N9RUL:79E9"!A6QE/3-$9F]N="US:7IE.C$R<'@[;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O M='1O;3HP<'@^)B,Q-C`[/"]P/@T*("`@/'1A8FQE(&-E;&QS<&%C:6YG/3-$ M,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Y,B4@8F]R9&5R/3-$,"!S='EL M93TS1"=B;W)D97(M8V]L;&%P'0M86QI9VXZ(&QE M9G0G(&%L:6=N/3-$8V5N=&5R/@T*("`@/"$M+2!"96=I;B!486)L92!(96%D M("TM/@T*("`@/'1R/B`-"B`@(#QT9"!W:61T:#TS1#4S)3XF(S$V,#L\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3XF(S$V,#L\ M+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0S)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0S)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0S)3XF(S$V,#L\+W1D/@T*("`@/"]TF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB M/DYI;F4@;6]N=&AS(&5N9&5D($UAF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/C(P M,3$\+V(^/"]F;VYT/CPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@2`M+3X-"B`@(#QT3IT:6UEF4],T0R/D%M97)I8V%S(&]P97)A=&EO;G,\+V9O;G0^/"]P M/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/C@L,34P+#8S-CPO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/C4Y+#8Q,BPT-C0\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/C$P+#0V-BPP.3$\+V9O M;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$L.#(T+#4X.#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C0L-C4U+#,X-#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE M/3-$)V)O6QE/3-$)V)O"!S;VQI9"`C M,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V M,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/CDL.36QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C@Q+#4W."PY-S(\+V9O;G0^/"]T9#X@#0H@ M("`\=&0@;F]W3IT:6UEF4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3IT:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS M1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*("`@/'`@"!D;W5B;&4@(S`P,#`P,"<^ M)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*("`@/'`@"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@2`M+3X-"B`@(#PO=&%B;&4^#0H@("`\<"!S='EL93TS1&UA M#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CQB/E)E M6QE/3-$)VUA#MM87)G:6XM M8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HQ.'!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)VUA2!I;G-T M6QE/3-$)VUA6EN9R!V87)I86)L97,@*&4N9RX@:6YT97)E2P@86YD('-U8G-E<75E M;G1L>2P@;65A'0M:6YD96YT.C0E)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/@T*("`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`D,C4P+#@P-B!W:&EC:"!I2!F;W(@ M=&AE(&YI;F4@;6]N=&AS(&5N9&5D($UA"!B96YE9FET(')EF%T:6]N(&]F(&]U'0M:6YD96YT.C0E)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/D5F M9F5C=&EV92!*86YU87)Y)B,Q-C`[,2P@,C`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htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies:

9 Months Ended

Mar. 31, 2012

Summary of Significant Accounting Policies: [Abstract]

Summary of Significant Accounting Policies:

Note 2 — Summary of Significant Accounting Policies:

Consolidation

Translation of Foreign Currency Statements

Use of Estimates

Fair Value Measurements

Fair value hierarchy:

(1) Level 1 inputs are quoted prices in active markets for identical assets and liabilities.

(3) Level 3 inputs are unobservable inputs and significant to the fair value measurement.

The summary of fair values of financial instruments is as follows at June 30, 2011:


Instrument:	Fair value		Carrying Value		Level		Valuation Methodology
Investments	$	350,000	$	350,000		2	Market price
Derivative liabilities	$	27,341,284	$	27,341,284		3	Black-Scholes Dilution adjusted


	March 31, 2012			June 30, 2011
Beginning balance: Derivative liabilities	$	27,341,284		$	18,567,450
Total (gains) losses		6,740,525			48,454,271
Reclassification of liability to equity		(16,478,071	)		—
Purchases, sales, issuances and settlements, net		(17,603,738	)		(39,680,437	)

Ending balance: Derivative liabilities	$	—		$	27,341,284

Cash and Cash Equivalents

We consider only our monetary liquid assets with original maturities of three months or less as cash and cash equivalents.

Accounts Receivable

Investments

In 2008 we invested in auction rate preferred securities of closed-end funds (“ARPS”) to maximize interest income. As of March 31, 2012 all these investments have been sold.

Inventory


	March 31, 2012		June 30, 2011
Finished goods	$	3,584,305	$	736,103
Raw materials		3,396,215		1,388,560

Total inventory	$	6,980,520	$	2,124,663

Revenue Recognition

Income per share

Segment Information


	Three months ended March 31,				Nine months ended March 31,
	2012		2011		2012		2011
Americas operations	$	25,745,524	$	8,150,636	$	59,612,464	$	19,223,278
Japan operations		10,466,091		1,824,588		21,966,508	$	4,655,384

Total revenues	$	36,211,615	$	9,975,224	$	81,578,972	$	23,878,662

Research and Development Costs

Shipping and Handling

Stock-Based Compensation

Derivative Financial Instruments

As of March 31, 2012 all financial instruments subject to fair value treatment had been exercised or amended and we have no derivative instruments subject to fair value liability treatment.

Income Taxes

Concentration of Credit Risk

We disclose significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments. At March 31, 2012, we had $11,249,095 in cash accounts at one financial institution, approximately $897,154 in foreign bank accounts and $5,000,120 in an investment management account at another financial institution. As of March 31, 2012 and June 30, 2011 the Company’s cash balances exceeded federally insured limits.

Effect of New Accounting Pronouncements

We have reviewed recently issued, but not yet effective, accounting pronouncements and do not believe any such pronouncements will have a material impact on our financial statements.

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References+ Details

XML 16 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2012	Jun. 30, 2011
Current assets
Cash and cash equivalents	$ 16,896,369	$ 6,370,974
Marketable securities, available for sale	0	350,000
Accounts receivable, net	817,158	941,802
Inventory	6,980,520	2,124,663
Current deferred income tax asset	2,237,494	0
Prepaid expenses and deposits	1,948,426	487,812
Total current assets	28,879,967	10,275,251
Long-term assets
Property and equipment, net	1,766,609	227,811
Intangible assets, net	1,912,399	1,963,277
Long-term deferred income tax asset	474,506	0
Deposits	342,173	32,173
TOTAL ASSETS	33,375,654	12,498,512
Current liabilities
Accounts payable	0	799,210
Commissions payable	4,433,803	1,999,969
Reserve for sales returns	764,894	435,135
Accrued bonuses	1,835,480	782,852
Other accrued expenses	3,643,826	1,423,370
Other current liabilities	90,691	69,893
Revolving line of credit and accrued interest	0	433,984
Short-term derivative liabilities	0	7,435,883
Total current liabilities	10,768,694	13,380,296
Long-term liabilities
Other long-term liabilities	76,430	21,017
Derivative liabilities	0	19,905,401
Total liabilities	10,845,124	33,306,714
Commitments and contingencies
Stockholders' equity (deficit)
Preferred stock - par value $0.001 per share, 50,000,000 shares authorized, no shares issued or outstanding
Common stock - par value $0.001 per share, 250,000,000 shares authorized and 109,219,361 and 98,794,499 issued and outstanding as of March 31, 2012 and June 30, 2011, respectively	109,898	98,795
Additional paid-in capital	104,260,897	67,606,293
Accumulated deficit	(81,792,667)	(88,453,607)
Accumulated other comprehensive loss	(47,598)	(59,683)
Total stockholders' equity (deficit)	22,530,530	(20,808,202)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 33,375,654	$ 12,498,512

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash Flows from Operating Activities:
Net income (loss)	$ 7,637,013	$ (3,604,744)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	322,740	157,984
Stock based compensation to employees	748,212	397,183
Stock based compensation to non-employees	132,679	53,597
Deferred income tax benefit	(2,712,000)
Amortization of deferred offering costs		583,738
Non-cash interest expense		1,644,158
Change in fair value of derivative liabilities	6,740,525	2,777,953
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	124,644	(402,390)
(Increase) in inventory	(4,855,857)	(977,880)
(Increase) in prepaid expenses and deposits	(1,770,614)	(266,637)
Increase in other liabilities	61,440	940
(Decrease) increase in accounts payable	(799,210)	104,101
Increase in accrued expenses	6,036,677	1,977,148
Net Cash Provided by Operating Activities	11,666,249	2,445,151
Cash Flows from Investing Activities:
Redemption of marketable securities	350,000	75,000
Purchase of intangible assets	(49,389)	(24,208)
Purchase of equipment	(1,743,718)	(64,743)
Net Cash Used in Investing Activities	(1,443,107)	(13,951)
Cash Flows from Financing Activities:
Net payments proceeds from revolving line of credit and accrued interest	(433,984)
Principal payments under capital lease obligation	(2,782)
Excess tax benefits from stock-based compensation	309,565
Repurchase of company stock	(976,073)
Issuance of common stock and warrants		50,000
Exercise of options and warrants	1,393,442
Net Cash Provided by Financing Activities	290,168	50,000
Foreign Currency Effect on Cash	12,085	(24,825)
Increase in Cash and Cash Equivalents:	10,525,395	2,456,375
Cash and Cash Equivalents - beginning of period	6,370,974	1,637,676
Cash and Cash Equivalents - end of period	16,896,369	4,094,051
Non Cash Investing and Financing Activities:
Conversion of debt to common stock		2,329,365
Conversion of derivative to common stock		3,804,936
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest expense		276,625
Cash paid for income taxes	$ 2,280,000	$ 56,000

XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 19 R7.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation:

9 Months Ended

Mar. 31, 2012

Organization and Basis of Presentation: [Abstract]

Organization and Basis of Presentation:

Note 1 — Organization and Basis of Presentation:

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

+ Details

XML 20 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Mar. 31, 2012	Jun. 30, 2011
Condensed Consolidated Balance Sheets [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	109,219,361	98,794,499
Common stock, shares outstanding	109,219,361	98,794,499

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References+ Details

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

XML 21 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	9 Months Ended
Document and Entity Information	Mar. 31, 2012	May 08, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	Lifevantage Corp
Entity Central Index Key	0000849146
Document Type	10-Q
Document Period End Date	Mar. 31, 2012
Amendment Flag	false
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		110,067,349

XML 22 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Condensed Consolidated Statements of Operations [Abstract]
Sales, net	$ 36,211,615	$ 9,975,224	$ 81,578,972	$ 23,878,662
Cost of sales	4,988,548	1,581,866	11,624,980	3,793,535
Gross profit	31,223,067	8,393,358	69,953,992	20,085,127
Operating expenses:
Sales and marketing	19,676,246	5,350,388	44,096,845	12,781,834
General and administrative	4,616,165	2,081,108	10,491,795	5,084,270
Research and development	378,098	115,515	924,450	315,025
Depreciation and amortization	146,063	54,084	322,740	157,984
Total operating expenses	24,816,572	7,601,095	55,835,830	18,339,113
Operating income	6,406,495	792,263	14,118,162	1,746,014
Other income (expense):
Interest income (expense)	21,310	(468,900)	8,570	(2,477,805)
Change in fair value of derivative liabilities	(10,686,945)	(10,090,924)	(6,740,525)	(2,777,953)
Total other income (loss)	(10,665,635)	(10,559,824)	(6,731,955)	(5,255,758)
Net income (loss) before income taxes	(4,259,140)	(9,767,561)	7,386,207	(3,509,744)
Income tax (expense) benefit	(586,653)		250,806	(95,000)
Net income (loss)	(4,845,793)	(9,767,561)	7,637,013	(3,604,744)
Net income (loss) per share, basic	$ (0.05)	$ (0.13)	$ 0.08	$ (0.05)
Net income (loss) per share, diluted	$ (0.05)	$ (0.13)	$ 0.07	$ (0.05)
Weighted average shares, basic	103,016,170	73,181,511	100,450,870	69,281,640
Weighted average shares, diluted	103,016,170	73,181,511	115,232,578	69,281,640
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(80,278)	(17,359)	12,085	(24,825)
Other comprehensive income (loss)	(80,278)	(17,359)	12,085	(24,825)
Comprehensive income (loss)	$ (4,926,071)	$ (9,784,920)	$ 7,649,098	$ (3,629,569)

XML 23 R11.htm IDEA: XBRL DOCUMENT

Stock-based Compensation

9 Months Ended

Mar. 31, 2012

Stock-based Compensation [Abstract]

Stock-based Compensation

Note 5 — Stock-based Compensation

For the three and nine months ended March 31, 2012, stock based compensation of $307,840 and $880,891, respectively, was reflected as an increase to additional paid in capital. Of the stock based compensation for the three and nine months ended March 31, 2012, $307,840 and $748,212, respectively, was employee related and none and $132,679, respectively, was non-employee related. For the three and nine months ended March 31, 2011, stock based compensation of $288,665 and $450,780, respectively, was reflected as an increase to additional paid in capital. Of the stock based compensation for the three and nine months ended March 31, 2011, $264,666 and $397,183, respectively, was employee related and $23,999 and $53,597, respectively, was non-employee related.

risk-free interest rates of between 0.93 and 1.55 percent for the nine months ended March 31, 2012 and between 1.33 and 2.64 percent for the nine months ended March 31, 2011;

dividend yield of -0- percent;

expected life of 3 to 6 years; and

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

ZIP 24 0001193125-12-234633-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-234633-xbrl.zip M4$L#!!0````(`':"KT!&7I'@(SL``%_@`0`1`!P`;&9V;BTR,#$R,#,S,2YX M;6Q55`D``U^ZLD]?NK)/=7@+``$$)0X```0Y`0``[%WM&YW/Z6(D6UN,?@![,3[US\M`;;P&P)$DJV; M_;`3@U#_NM7=:DDMZ?2?+U-?6N`H]L+@TY%\C(XD'`Q#UPO&GX[F<<>)AYYW M],_/?_W+Z=\Z'>G7\_L;Z4<\F$/OOJ1+]+O7"VC+SQ))'^WON' M]+24[N^EBS`(L._CI=3IY)6<.S%\&P9I;8I\"?`$\:>C29+,3KK= MY^?G8_+X.(S&704AM>L%<>($0WR4ECSQO>#W`\7)ZR>@EQ=_V2K_K-+2LFW; M7?IV5?-H$:Q*^MX(.^[""1)GC(^'X12JEQ6DJG)>W(M#39'-0]#3$OD'(-VQ MX\Q6'XR<^(D6SEX0"G('R9TU#5*?5T$XY*V[_H`M;'33EWE1%V^4B_'P>!PN MNO!B%Y+8VR5%J%CN_OKUYF$XP5.GL$#S2M)IT2Z)S%]=8]'$I7V2;*=^00W?3:)\.C3$6F`3B[FXY?8/9*ZN0[UPB#!+XGT@(<)J&ZF0=^ M.CIW?$+Z+.Z/'I'UU5F2F@B04QPD7K(D?WDN^7ODX4BBL'"!IUP"O>LO1Y\1 M_&=IMJP9I]WU9Z22[KJ^&8Z\T*4U4\Z3SX1H!^D=9)UV\V?DFW7);@;Z$'Y5 M!@-[0_PJM'PC_.A?\X`HT5O@!\TU.BJJBG\`2HB_PH-)?!FXV'V#1@"X47(! MGC9K!F*#I]WU4PK#90JD[90_:\CGZS56@4^YC$^Y'I^W7O">FA.X,-MHSGUL MOE%KHC(V:[;F3N_RV`NGTS!X?$C"X>^/7_'T"4=ML!WC\12GCB3M1$_PR\SW MAEZ2TI1<#]ZG(576F9\$,`<^>KR_^:`!9#.P@!^QFXD067#X&C)">X6\YGK>J37=?S'.\=S'Z^#QYXS\Q+X_:<4^IH?PLYUD#'S M?AO@'B<.V+G[>.E$`83J\9]3[CD;.1?O5^!GP^%\.O?)H.>QGTQP1%S-+,(3 MPOD"@P7`D`#_.5N!X8VR5N`L9>P]-,R_YGY'[M#6@!X-N@PZ-/CNBWA;X%6B MCSV-]+U??C=-\;WK>(>-\KU[^3,TWLX9F>^^;6]'+V+B:"7F[_W\&S?`]X[C MM37^>Z?PKAHF&PRBMYC#1@(&LZ\^$5@<\_'*_V^=SK?`6ZWLT(4=Z71.'A&6 MOCU<7-X]I`M*TJGK+0!(^D-*2]W.IV1U,HSRI_!\BIUX'N'/V0K<"51RVLT? M2OG7W9V?TTHO.!&.]]6[5<-I=PT^+5)D](%6ES-ZF!1= M75O549165D.)$`HUI*T@7?K4DC?6V.#-10C62]Y/'3\W[`37:;1(R^Q3F[#ARHKLG7E^>`;X?$X MC+B9>I@Z/GPFW>-9&"70QTG$NSK!DN6Q4'-.-&_7P7+&S16XII_3BMFO\QK/ MX(%+'E[YSIBWRI'CQSBML_`]L:@"SCOJ0"HV`]L;[*UL4R)I.Z5%KN!9S$OM M9[5(9:NB+:;6*E&)$/G_+E*KBE:$,B5?!_VII^G/$^*:2>9'@>;N=73)Q4,/ M%"W^='1]>W4D$<]!B^=N2Y81,DQ5LPN6=8!HYEO`IZ0Y`[G[B27P,=+YV_R\>&GR\O!0^:*5@,8)YZG$4?2"]3:R&N MN2!^DV$1^GS9L&Q#-8"=2E0%PERMH1^"::@FLDVM`/YSI./K\+H`4J# M]Y]',%3!\05^2M:_,@_64*QHC;0BX58P<\E8U4F_(0;X(-4<$I?@;$VVD%(=TG6P@"?04<'KAE(Q;`OI"M-X;-W5 M:7*QKQ,&50%-74;,8M'"#5&!&74!`W%I(& M=G(7X9GCN9`KO7,)(*QAXXUI5A-387 M65%M1E"'J8G`Q:=&$)PIIED'UR[WA\$\%C4:ERU5 MUZRBD6P3:8""SU(MQ=*5"B#H$E)6ZL9SGCQ?X`R%:FBJI3!=^&%J(G#QV96F M0*^!:N,2+B@;&;:\`4U;:TZA#7@5+D+`S_^0($6Q#5X`FW8H;/P`';>ZZ09WTFF*AG.R#\EF M530[M4B8@,I,2#`FWJ@0Z1J2:T%C"C2V(DN#X=!N*ZI,DF^,J:K(,.5RDC1. M3N@2&(F(@2CX9!P,"81B_2^Q=Q)X_J>C!!ST$8](NNT26@NB0.@NRN8:Z`I@ MS56Y#0SU">QK+7X"=T[4CVC&DTMIW>&(+FM698HDM&PLJ'Y&QP@5)O]X"(N$ MNEL\KP`U71D^FR>3,/+^P&XE:6;+SYL0Z8I=8='N,$T1Z'8(\)707$0R_AN*L&/)IJT8;&)#.4U1"+E$V+%@$*H: MJ#9"CMT4-V%,%G;[HX'STE2@FJG;Q<2R*M1;`QMDG4!<`G'`59R%+8]+S#")A9B[/`%2Z0[27Q,H)BP-5< M1N#-5YL`Q58=7M119-F0F MK27Y_1OSAW%C=A$Y5:8U\R1RQ:IF68?"1[X4Q^)\? MP]"EFH6CA3?$\0,HEP@]`#VV=*TP=-Q'3B2H$O/2+1GDTQ*H>BH#UD*,'KTR MJ)*Y9--6=56OBNG'"+JUNR@<>6)\B:PH9$Y[#8,AT(CN8>XMU595-L6](MEZ MBF#8MJ[:MB*<;(G/0(CT..5"?L"^#R$C-#\YE!63N?PLBUA$6\LV!/R*QMCF M?GHB41T6#M@`4BVK)5#U]$33$(2;FO[*H,H"%Q-^>N3+`!WZ@5T M'R99JA.H69H!\8C!B*N$IG!X9?9GR3*R6H=7LW="FBT7)F)?&5Z)?2)+4]A< MI0KH2":<$PTG=`O$`OLAS7D7J'BJ:2%V/'N0H&!D)=8JZSH;HK>`K)ZZV8JF MZ>A-@)4$1+*.E#H2N\`P]!]Z--$4_O8Q^8.HYY3LH4X34(7TGYJ!C&**>2G= M=G"66*R&+.T58=;30U513`V]`YAEXQG3;B+-_HP<2;'NF6,1FJAH%G2W[!AX MBXP`#"7I=`:2$=MK-8!03X-TW8(A1"%_3#R$$NVP5-669;4JA/4,I0AU,#1D M:#N;8DU'"(RR71J*8NP213T4-:,I39;!.':9AE@8)8IA0F?!)HJ5H,@S`D-6+NP@G&XLG==5!1C3IF!UG<))O#W+)NH:,D(UL=JKYU2#7 M5#P#8AI=>0L9U]/6CF*:,/94FP&^#8.PZ-]$^C%07$,WV*G2O?0$@BI535VW M+58U!8*JK7RJ;.OMR*FF>H$MZ"8[S\L%:=U'7D7A-,UJGI,MA>F781"?XU$8 M90N]`^<%QU^]((R\9)E[6PC)B[6D:WE?<3()77*(1YQF30O14$W1;5DK]#BO MQL"[EEN)=MBF8>IL6M%_F=SJV;FI6H;"9IQ\EQJ/LJDZ.5U+>R=B@^HRQW>. M`RQH-4^WH*=4-SG<(E453K)=G;)\[L3>LU>@; M&>/D\%!TS(X'=Y(2A.5P]GJ*A6T*`5@XE6(;"DC%>A4D/$)IU$`7GC]/<+V< MGLIH,F+"\#15F9IXFJB-^6IHFJK.#CB_8'+-+G;/%A!EC/'MG)R)WA]MY:K7 M]$#;>?)TB5E%LB&S/XUX94O6V0/5W@`^C\;ND3[2(!1Z8^GS MJ/A.^(:M6+*AM8@^LY+#&T1>0_OW`6F=!W$6T#8+]:U`UA55T4WKW;(@SA)X M.-BW;>$*1IS>.$A/X1@N!Y$3Q,XP6V6FOWPZ.#US_S-/1Y?Y)H?T9'*H)<). MC"]P^J^0D8N%%+;A7@O[^Y57V>RPJ>KV?Z&\:J[9*LC2OTN+>\E&LY1W*BYV MS]7;NZ-R-*_)DQB7\28\M6K6[XHC,:97C:4=%>S<-5E[VM%6#&06-V_O(R@4 M5^F4I`704&NXZDY7:C;:.)#C-5"53F4JMKYQ%.LA6&4;%A\&_=Z7G_HW%Y?W M#X^7/W^['ORVN7.QTM$&.^_2K+%]?]\9!W7V@99@*CT01?PV7HZK,*MMV&\! MXM[+(BON@V]#>I6N5:RRGYP#;*J3%W-RMG'JU.D9+_D4,78)%@"RG7E<^_KS M@SOH+&2Q9[96QRB0PYI;>86P0`\^W?-IZDWHR_Z,+NE"[/N+$Y&;Z.++%QP- MO7C#NU6X!IWGX!1=TU<'0S<"6<9J*J76.=UY@)6N'>:0"]NK,=C,[F0;.F*3 MJ.T[Y+AFH&Z3+,H\V M$O2%VB7$G?JF]V^"E->5O@[7N[+B;3XW^QZ9;6:OG79YO\>S>32(23U8=?<'=D$X'HF+1Z$>X[2 MRCSFCF%5.[V5H9E68?!?&:0X#FOV3F)9>).9WGUM*VP\\PZFT/=G;XGT(/S9 M9-7.BJP=X&^>C"AB`H,35/EALN+&X"M(#?W1]J&(+6"L.86Q==A@&^(3-X6Q M<99?O8/+>FW?1_V3JXK*U1OZE9"GO\&L?D1'TH)4<.V*9)N82S6P%\<:-J")\Y.:E MJZ5$Q2,LNWY'8EK,?&`%VE67IL@4S6B$APGU_6U-<'94 M9.OL:>0'P*MJ/*S:2#:O4)>X@WB)D M+@UHACBUNO[H\@74.1CC>R?!_8!41"[4A7](%[N`J%"05A07:JM0;Q5UM8T/ M=6'O+M'>#A1R%I]:N..R`H!6@9?%V+JAFJWA/@-#B:(EV`3?-:*H9(Y?-0W3 M*`.[050@2LZY=%M#;,S'C9+Z[UX(L6`49XLH3\D@K-K7EMTKI-BJD:=@'J2V M!U-^6*-H9*J%8$AJ[$2VD^:N\U5)K"-"2J9A*#O.5B75[SQ'"L?;/0 M[A.D4A)-J9?T=$89;;+.?X['7B"=^Z3=!\YXC%WI-DSPQL)^/QH[0;8@"*T9 MA[[G.ED*T!T($ZP@6RS,>D['IU?:TM#OPHN'?AC/(SP`CE)2?,+]_(.??`24 M%_W>X+>[2VF23'WI[MOYS75/.NITN[^HO6[W8G`A_?K3X.N-)!\CB:[X9L%R MMWMY>R0=39)D=M+M/C\_'S^KQV$T[@[NNR^D+IE\G/W929@OC]W$/0(9_#!. M/O[U+Y(D94#VBDN6.E);PMH!X^4I\C_`.&KOJY?-5R,0L!0G2Q]_.B)_=T;. MU/.7)XDWA;@JP,\2!)E.<"3%WA^8'%-#OB8?/N5_=)\./.J2.L40%%35ZNOV MZYOEE4V="-2CDX2S$]F:O7S,?C^%21).3]#L9<5DL^;(5.X'9SK[^#\D,^:C MQ"J=Y`2N1`Y2B:5P)+$J=R+M:3;Z8U;*E;&+J8\2,>6.!\8;)"?:_S9C\DDG">2,X?1]`<)!J-D`)A(24AY3H!P-/G>I+_G3:*@CP^7O=4O^>,_CJ7K@%83SKR`E,UJ!0$X M8\H+>7+CC?"_`91#ZXUF87JJ9*%BI@Q#0`HC6A]3D$P$.,&21?&!E(%PTR.= MH#<]*%+)\7TJ&6<]%_&!MHA')[@(WB",H,,!:8%H2)9SL6PR<4#(CCV(F6-*',D4:.%Y&F6NDHJ3:<1PRT69CZ9U?> MVS:2[+\*D]OQXHLB5Q0I%:'I8]G_[5T1=U M^8XI10OLQ+)%=G=5=5U=_:L`S,;ANK]MQ_V]'@E67OXX+E2[XD*=EO,YVB60 M?6<-GEV$IU?Q(&[4/2VLLB?J[^[1^*CX?2`SN2M(Z)UN2:&^C54ZNWPFU$BH MJ9>S-(XO3])E`N*:EV/P1"*?:@;QR1AM]9<2Q#^090$LC_/MGM>7MU5GRAT: M9O:9_BK]H"SDJXLH2`4M[[2!?_S6^$3_OFW\N^$]^Q3-R7SHTIA+3WEK\-:/ M<]27?@A3<$<0-WX14H!+H:,T]RJM%^$S.,>^%_MZN""BV:<\^P1'^)JE81D4 M\-TW:7AIM3[_U.P,8=-\CQ*<&"COU^!YD%]YHCAIN00381_;UF/GX*072_33 MD9_`8/:LK?L.G('YDO6/$L<;@&=OZ<(\I#YQ+D*A3*I+4YZ^->59&U3_/?FG M9$;AC9/MOH-VT]5*#0@C,:V/DRP.*BO M$R7P$0\""?S#F'.X7CZ3LO#0-_0@RBW!7U0O3=`]UACZ*#B5#<]N%%_T\:2Z MZ,-#SF!GI!GN_^IDJ^_/N&>[@.]PJS;A3>%M.>\U<"WH5SXHG\4B2Q=9!&\` MCWVI,!\]GT$?5X;0;A8[Z&;$]91#'23]CYS"CO<0`X*C*?=`GE4\9^+L&00$ MLP5`5?P%`Y'Z=AI$RD.CYL6,++6\WV1^G/ M9ZWGWB?LJ>RU0%@6I1+@_Y0ILA,L74!Y&`^]NW-,:V)W>*\R0C2@.%H&2"`AP/I'ZB/W$T0K,"IPA42P':`KY$+A[F#<%W MG^O4DE4GD>GD5UM&/>MH'G5<'I6)0SG]>Z!O[BA$-NI,F8VZ\0:+IOGBO%ZV M[)JWJQ1>LXVJZJ.>SEP!H-E8(3`:?_`J]V(B.B;QE&':IIO'6)F(63_\$JAG MK&;EARG5>,GL89&'KZ]S:"MWSC!S"1XV)@E"-RF>>/3AUR_Y=-JRW" MM0?.U1R83&9QG6L^_X._=)SN7D[7.L%K(KLNPJN32-)EYB]^?<+_WE9OM:HA MG>T+_')7%'J$N*&KX60!'50@@IWE0(K:F-%\2A]!Z;?H]#<^T>3 M_G=/A+,A0RWI]K.Q0Y=\TB\R[P7^[M]'[M2$.Q0,_%2>`JRFX(#^8\@D'(R>;*5PN#6 M5CW$5=\?7=59_^$?WDWC]]I"7R5?UX7J;[A"I_>2N#5QPQ/5NXV M?J?7%"#\UYK%ZC:[3SK44K$<.7OD[+VOZ!Y9W#XR]]Z9^YERT78"E,^^KJF^ M28CYB&;UW<:SK:.%?9A-.A"=;DNTA]WC;CTR]\C5,D_().7G;:X1]ZZ$B'5%CV MD4EU@2/W?+Q?E"8!V&A3\4+%A51"1X?HSJG>UF,P?0K(=YHJ)X%8+>Q<8AK3 MW3FN8G1/(C>=)S]3Y\[/O9#Z/*Q<`+K.S9]KW;#8F].Y0;^^IW.#YAU/YWK[ M=7Y4H^G>-4QX<,/\,$GQQTS#;M$YM(R?)2U>%UYL5NJ/QHIC?MWZ8;B6A,T^ M72YXZ1US`\?PL38J;*^9VQJ*7G\@NKU]R,'?RD5Y9.UUEA80YCRC2TC/U06D M`U54M4F%],6@VQ2]=F\/9/K(Y%M.I#L$K=45[4%K#[B\2W/MCR?V30:QG^>4 M;=%YGMA<:RY23]*=HJ-Z>UC)?];JB^Y@*)HU$/WG1PWW8'S^+WMUSYG3S697 M7[575R7W56%@Y\++_1C_B100M;J;)(M"M5P4\([BJ.T>6ML-1+_9$8/.\-$E M_JCM'I#/G9'H#YNBVQGL`Y]W>G2;KAMN]^K<&=_T(.'6#ZUK5Y5GI=/$S4G6 M74=0]1GV2,<'IN-A!#/OD_"84SZZMC]+WN:Q.;Y7IP@';=P[8!W"M,2CP1]J ME>YIW",E'YR2USQ\KGFYFFG[A/&[#!G)-J!6%P5V,O1".89Q"/6(8"V64G^5 MT+>^I.>2P,?:S>8(4:G3,:S/S M0X4?9J&GEGK=8TGE;IGT%JX#/O6A)<[_,CX49WL= M1.)=2U[E!@+KY'D:J(I!8HY?A9NR$%/P9:J5H5F_!OH0*@GQA3"I#"WDQ2+* M+`3SZD-4T4<(EGX<*Q1+U;OHE>&6$/)HQ.OP&*ZU*]DH0K)%S%J]S) M'P[@AIUR:&WT@]M@BF8W-O.\X:1_#`JFAJWWT@2QE,H,:SIE@=LSCF`MH89A M(O%*P8T!D8J]N5_H1@'$'L2;5\6@B-8V&RR-X.@\1[\8^*)0Q M0VFYSRRPA1_HH8R1^%`QVZ\K+-,=^-BZ&TTMR!T)C`]-C# M,S4TX7T%):B\.0BR,S?6T0[LJ8MV[^OVQL)M4('`F:%$E##"V6-\L@257;JD MI1#:'W@.Q:2,'8SF1(U+-""Z4.K;!0.,X'N,4Z80T$*YD"0'"!]89-&X+!"X MC)[;K4I):=J."9<-,+5`;(0S'!<:II/60AH::\LSM*V[&D1<5<9]79S\FF*Z M.G?,Z[^O/R9HFH?D3]&\E;DO"5>:$747U/L`(;]RV[4%]W.;F'`ZS)&[@5I M@(W/R(WLV#9`+^<%@Y$:/6GAL"=1EN,$A<6.R<8A:Z8]EK$"/<1IJ=+4/=OJUVUJ&1(;(RO:B M=9L<+[IL++.^X467[ATONESW^1_\I3V8[JV*$HZ7*^[WHLL.`Z.O6=Y]V.-E MFKIV*G!R>H'[&(S`U]AFJ;A\03U@:[[B]ZP*SK-8XW[X?%VT.F+ M5G,?`!WVL<#SFQMJ':AVJDU57T=T1GW1;AW5U`$SN24Z0[Q'N.]W"/>^M.,P MZPV/=#S6;:Y>J#6IR0,UX(_M@O;%:(A7:/=!I1]Y>\-23-%J=T6_O^\!QMZ; MZT.M'SQ2M?:8;E?-635=O$ M3S5`PT/2$HMXSB/?^^/KJ>IFC$5)J'-C?2*<2U4\HQNUI=SKSZU6 M"F:P=.S'J`E+A:JJ+$=/B]]2<%FB+BRB)F,9L^%O//)>8`62G^?8[!A/EZ,B MYIJ:+,J_T\7^-*RH)1Y(V;^XM8C_`5J27=H$-[_6D`/9UFAZ\)!=8P!*F M5*M$1:LP-M>DP)"*YDQK2Z))JF=(72;5"?Q'YF@BBV6:?5?U"(1=R8_/_"21 M,8U'I5H>5R9P4V.GNHI&5@0HDW0AJ7@AH:)7.QZMGDJ_8-!+KEE8J$O-H=L* M<)%%*'I+&9_K*BJ!&4G>P6<1523;N245;EGFF)PF5:6N(7ZJT M$,=>WEA?H:J'D?:)'U_^;% MUD\'_:X8CKKTMZ?=3D^TX/_XE@47E\>7-:Q!_4AU5]@C'78LTK[VFOX-\#:@ M27#-&%7_HMJS:XBP+_=\41:L*\((%(T!D97%ZH.JPG2MG;QM8ZXKW/'M(%-E M02VD::]8>%KN,]_P"&D8;Q7X&0+@\<3<-Y",;YR@,[DMD^*]4ID.RMLB+:0V M4WSQX%Q6QZR40G^H%&62%E'3=RLR/;-5\+M\28)VE+\`K75!U@#&:_<\X%J, MBJ8Z,8)@0$^'[):NV<<7+-?O%;"-QFI\R6I>E5!-9$9$A%72VE/5/WY*QB&L MZ)-VLSD@X33OQ0MQ#&,O#+ MG#K#1YE:.6URYV;'N;1TM"6M&\BX0?7LI&>K397)56)REV%7F8@=]-U-I!]+ MFTV%OXI*N^M_6RMD(@I42=5OVZ!$A_]!$82?H"'H."+!U2Q#WX@MY+V M<_.T:GK.7MKJ%.,\==U%_0Q[3E0V*I/S*$N3.9L*OK!#7GU:?9UR2%^#@P?> MV4K3]IS^]D?CM"&\M^"CA3ZMY;.\B()474;P_N4O_`1BC;4H*\9]$$?GTMP% MPKG':>`[5^;PY;1T%5>1(9_*%+;98H:TRZ3/:S9MFO>F"K;6S9BOVS]W6UGI MS]8N^#C=6DWW-C.Y5C]NO5_O0,_4C'W:/4A_U,GJ3]>*/BY;H<21T^ M$[]LP_5,7_]>,$8]7EG]DQ'%'U)$1QXLJUR\EZSQ4*9G) M-]A4Q#K5CN5D]U%RU!.#;D_TVON`_G9D[LW&'XI6KRGZG?Z1MP?'V]Y(]%MM MT>T?-^[A,;-JJ/EP6PW97](;[H+6.3+YMQ-`2(]C*O>:1RX?G>'1%O]<3G2,6^&/?FSC, MBXY'.A[I>*3CX=%QIRJ^[ZQS[V$O,*O[,(<:$CZVA]%!T)&6Z!^!1PZ0N2,Q M&O1$^WB8<("\';9$;S`$!K>/S#TXYK8[8@C,[??W@;D''?@=ZH7Y(R6/E#Q2 M\E`IN:J2S>=]@E(]0X"P#A=T+TM[$FP!XT]:/P_I6G1@O>K`IJZTR@F MJD:CYI*[/^!6!9;'E##Y*9GP@UO?;;U;<@6]6GSGH[:7='M M-?E:?:?5$\UV;_TV;`VOUI\B`H9N]/`;_(<:/>R'O%3F/M-S9['1'>!T=[XH M&:E&!-^A._R52ZXY==,@!(G&ELE-)*-R M9%,6:5]=C+0X'ZNO5:^[-A\J?N-#M8IY6)'$%GTGW/'JK7-YV2K<.DOFQ\2B MFT194,[QUF@@&?-%W;>N]B($%10EYVD44,NB[#P*%%X"WN[&9H#F_FL>%:6Z MUXK8-/ZEZ0@#$DD+Q\?.05Q3Q)SYJMO'P(M41\4H`1$N35.9)$U.Y'P1IY=2 M*4,"5D?0"3L3O)S*_;Q4IRRGJ4VEK2/=K04MFR&VQ3PEX!WL6!A?>G/IYV6& M=O*E]\Q_;@4.W[(^IH(V"E_A;Y^-5[Z_82U,V)JVV'+Z?W_@QI-^['UT9E][ MH=;F66$6X?5]IROEBE#-9#@E2Y[FW`$UY3Z'DSA="G7O6R!C099``<,^07.= M!)<$$`5R^UNZ1"FB'4/(/E1)K^^KZ]W%6V-B".K.@KL<\=8@Y"'T`7B'@-*7 M!AC%`"$0=M1\+,.0MB=VSB)L_/I.-:<,VA,L(HTKUF;OD]KIV M>/W8.ML=(T.,U(?C-^M[&9#*Q07V$U<8O"G7.62Z`Y5]*2;2E*2EJ"F,I@ MED3_*:6C4'0G6JL85,F2!6P0EBD6(W0W!<1.I1]U$SBY,*'A#:H]':IT7!-(-0IF& MND\TF?,+#)!@>3!U;J[L"O\'W3<7061B>;'%\!@EOUG!TWJF,I$9P7P'C.QV&LQ2W."?0<,CIAMCTB'A&.G%H8P?_E7FVA>RZ#_$;M5.6QB4F\J" MXUA3BO0!N'.(^Z$1\$"[V+@#]!;]>YY"^$MPA\(!-T0@O%Q84$5<,RFC_+EM M?HKB@NR']?+^*U;-#OM+[_FU%)[<4'J56F,<%3?`1B:":2>;IY2;PG/!E^F% M**$`]<5K(?R4Z+LD8#Y!:'N((8D>)0U0(*6 M4IQ4FT'9B(DRU380@)`Q0@2_FZG?->UK_097]^:,%F@PY6CMA"NWC&(L&9C$ MA+4#\[421U&M6@P#D>8N[[AON9'>^BKI*Q`68?U;S:*+0N18,NI\K_HBAZO= MWD$K^'/.'E$+>>7$@NG?XC-O'L/V>C>CU2=_9`8<<\Q+8G7F7\@]"&;4;`O_ MPJ0;%4`B:8MH;E*`$,9JE$_V%!<+=@C]Q%'&?I*4B/M)5H!Y:P8@W%'@*W:' MAO6=H%.N_BZ\15SB+KJLJ,HR*7-\'64%)IG9UFF`81+-$EQX#6150;=5"J>Z MBH85^3-"9DW/(PYMTLR9J9,+K72M)SFFQ:^@+9H$:!@AUEQNL7J5/TVJ?9F6 M,6X0#:1+2)*&C/AM#$E*@O1"J"P(N$*TT6LTA`W=ND"I(9\A9;^0H853A*E32U1/(8JI4K?([9`YR#[U7["W\S#B MMPB'^?1M.8>WH;/DB((PKBDY(]$L34/JI`P;[9Q@%6GQH>XSCH14"'#L8CKX M;YS;*&@]*UM1)=5P\9:R9U4O>MF8H=2*3#RRU;4D&/3UP^> MKCIQ@I>,J:>X"?HV3!*V:QFS*Z_5,4AH2<*O1=(&-4:MZ3^!;CVG3?.?TL]` M&>`1FA]'?QN5@NM=EWN@A-H1^JB$@"(G)06'!F(83S-@WZ/"H&=7=B;)&"@* M=6:BS(C.*Y.I*Q.EB\A??P>1#H$?,QPV8JK;SNL1@XK2!M`Q!0@KJ2,-8;YI M*<9B9;1RI540GE01%\>!2$-R;##CP'D334FX")+>'\?@\#"VV+0HOG4 M=W^_-^;L7SY8NNS2+I36V1PQ^#WK6MIVZ'$90>(HIZ)3P4/1^D`[*2YE:&/Y MB7V%48R+-.=&%&D"TA9-4`:CJT007VT>I&!LC"T=OD`Q*\+1(Q!)8:VG&HD@4U6J:'6%E6X.NF6$B41M"IDI M@6D7]I'L,BI3B:FQA!5T6OF,-M04`QL*[H$JO>8O*_9V+'&11KQ)I^#VH40; M;(R4DRV43R>G4B78'<>`E*Z_1#9$R0SM.X7(G$JB#8+S9Q%92<'/_>_235JX MB1I4"=K?R=4Q_]3/0L>14>$%GX'P%)7^,"D@5#AYKO,EJ%I=8<`N!2')"IDH MH%`T7_B89TI,3Y#U-/_=4_P/'BV^30DVVN9RWG(?DF^8R:I]](BG8%$>Q"EV M57'@KVL]T=B>:H1TD?>@^KS!S#`SP7J2:CHH(3 MG3HN=O#.GPY'`]'J=J2.^L9]\=]Z(53(]-"RBU6Z2+4SFN`@W812(D^FG+R8CJ$ MII,.BG!JM.7,;GMODM-?X)NO;\&5>^2I:9%3$10K=Y=I0R*O`; MZN'_?E'F)U/?7[P\M5O;\N@KMB("XWX&9'P3I\'W?$CNB"1?N&=^5,L)?J2 M@DD\.=%_9RBU;=^()^?)RT_@7OP^8=5KWD]'I/#AFYS\^@1A4#]39/(>`Y/_ MZ[1@<^%F>O)/51CY[O>W9__[];TW*^:Q]_6/-Y\^OO6>G+QX\6?G[8L7[\[> M>?_SV]GG3UZKT?3.,C_)5;3YXL7[+T^$[.B6+Q\\6*Y7#:6G4::35^]JX;(1%N&3[=AQZPON>"?>]N6NO.B'[TTU1:-QVJ\\G*=C$_=A M5[H!C@^*D!>@[!.&*&F6I4MPW_##$+P\Y>PX1HJ,CO*F^9R$JFW5P7JD'2AZ M]U(5HTK^YQON]A1^I<"J.N0<`Q1;*:'+C MJK]`.2BG7<7C]MARYUALH7.\@^*1'Q'NU!#;Q?=^M('10'@(-4MC[&'VGNI6 M\$OOV-X2J(+2N+&5*B%[NA6=(<[=\>+\7@=]=*Y*D-GZ MRJ'H#5IB..0V9R/1;8*SV>F9UEB3RL'KIJY%%&MRIGJ]^T[#N[^98G?[)M>- MMT0/7'#\M&6>UYDCUY2F^DCVBHGJDRZ5U[UBSE:7AEZ[/12C=I_>UQ_PSW;: MJV?;JU-';QZL`=Y6UV733SMMB@@X.!@-^J(YZ*QVIN-#CMSH5]/#RY38H0V: M^A@8T"3`]ROG)9<%A!+\*S!)_I9`@8C`P4)N2P^U'QEC5JC@Y`"WU*2Q[U$6 M6L#]=J_CD!%KS+*(4GVJ1$"E$2J_]=",ZB)?RCS3D0]547'+S)QK*"9($4H- MUC:=A\V`7F=%%,1,`3RKS?"$AG.KG._ZFU-6U"8KX6**1::3F)HMIHAT&[N5 M,4\PMK7](Q4O$E4BH5(O6)HZG7%I(0_%9X;T"`K>-.&DD4JB5^:"K@E2_DV* MC59A+N^H^R15G=25#^O9=>6>TPLJ1T`7%_G(L@WKO.BJVVGN,7HKHB^[7"X?FK/\5/O2)M: M>*^]=>]5:0IW1?7W6R$&]D-PN70%@G9,U([A].BYVJ;42W%;"T7O&7Y%4Z7= M?$7?QK^8W[5>/1?6*Z&E?X&7HZ:VYJW-9U]]X?:PCO10I(^D:I/LF?L_0K5% M3C-S@0+UJ5*PH-E?6HL.YGDD=:D!1[,F7'>PA.^B@U!HNVS'U;6FKAU#DEA* MI!/P%>DJH*&)V'H7D-YW&D1(73S;?AV>1SE6-+'%?^;P\_3U&Y>3WIP81SEV MLI1HG8HEKN)IL]%NL3/<;`SZMG&P('^/*OS1J0-+><*UVRG[GR?HX6G'WM". M.WE3JCW`*^Z92PLWC(`]U&TM]U-(7H]%`]'?+Y"K7-TAE?9VR&^J95I-F M?`-=TVKNTC7>J82Q5Q3-@+C5O$=%L_L8QU5#P/&KM1"ZI7Q(=>Y',:7BJ(I* M!P^N!*CUWUTOW4`GZ3&OKY/XV,)2<)/JZ'=8=;0:@Q[7)FQ1'P5\GQSM$W)2 M@7RK^N.^-JF'"#U=8%?GMAM4D8I.-"FXYT!W+B6O9U+=#C9O:R-[?&SSGO%A M?EU7G-8B#]MI7?XD(-)$RY%%^RXR)@-HK52\IS6[55:!I`KLZ MQ5_%""4'3.]*/W9*?#8'8MA5B<_AL"F&H]9JPA0/I=0E'NYAYY>JJ*QATAZ*-OUY?@39FYJ86#82Y'C96G;;H#T:;GG2! M"O33C3OPI'4%3]I#Q)+K\;RZO:88`%\>B"?$C0WSN#U/X+]/V_TNK*"O$&FP M(F?8N39/GK8[X$V/5*$.V"%X_MILVKN@^K>QQ&8$?!^J,8".T!5L-?4GH M;DK97)V@TB,['-U$/=&W4-7U4_3KZ.I@&LJ8D__<(YZ*/YUZ1%+,='4`A<8U M1B8%J=6VLXI;@Q[=JD.]DXBYT;*[C2&BR3EG.GC=!J7&L>[GAK"->W'AP+%D_HOG(%12'G M@E\.8)J-D7*1&KT>RB;&D[>X,H&OT.]L-3K\SG:CW[WZG?;*V[IV?;5!_*]` MD=N%$7?<(O7;(NW'W")AA&D4$-7+2,9T8GC2/-$B>Q2^@Q>^SF,*G[EJLWMC;%23?81O9P_HXGP=<\LO^0ID6"OSGEK#C]`:=Q,`L``00E#@``!#D!``#M7=USV[@1 M?^],_P=6]]"[!UF6G5R;S*4WMF1G/'4BC>RT]W8#DZ"$A@)4@)*M_O5=D(1$ MBB`(2HH)I7VR+&+!W^YO\;&+#_WRZ\L\\E:8"\+HAT[_[+SC8>JS@-#IA\Y2 M=)'P">G\^K<__N&7/W6[WF_7DWOO(Z:8HQ@'WC.)9\EWGQ#_Z@W88LW)=!9[ M/PY^\I[6WF3B#1FE.(KPVNMV52772(`LHVEM%V?][%E$Z-.8!)BH^=&9Q MO'C?ZST_/Y^]//'HC/%I[^+\_+*G"G;2DN]?!"F4?KY49?N]WS[=/_@S/$== M0D6,J+^5DM7HY/KOWKWK)4^AJ"#O12)_SWP4)U:JQ>55EI#_=56QKORJV[_H M7O;/7D30D3;@+,(3''K)Z]_'ZP7^T!%DOH@D[.2[&UU/E\Q\1#;Q4 MV"L#5B:U-,$UBJ27/,PPCD6=T;6%BZP=C&&,..@XPS$!TS<"I)4LHVN.[R&& MYB\M+T;A:"$[`S!WK;',4H=;+5__0\S\KS,6!="UW?Q["9[1!%VU]'%1#I"8 MW4;LN9'I2D(:3/I&:M,<]1Z=M3_HJ;T-%/@\8-#:J>S-X9-@$0F282&KPTLK M\7[\0M$R(/#DIXZ^NTAZ?^87'D:ROV6\:)D,>]*IAD@\)3TK#%-3A!;0P_;[ M/1S%0GTC;=COGO>S#O:'[.O?KX0`7(,EE\U#O2!"3SA*7KO[O/?*\"3!T!O* M/]+Y5BB2Q%_%`\3Y&@;F?Z!HB36P+>5V'>2*%S5#W%>5P\>"SY0'M*Q$3RSG M::?;!9[G2C[D;*XU:?8^U@@XX]`>89+2\98",+&%?)_LV)ZQG'4D3UZ;JZL5 M(D!!A&\9?P#<#]A?%G"()&."&>,$$ MV4ZKE'7K2CMFW3JXF75_=LG74VTJYWJMVKC451@P3 M_21RAVG;0@8%^K[:7-PATYN!9DS\U24F;@D%!>_)"@=W$,K1*8&A?=/C:;BH M$W"(C3JH&1_O7.)#-^Y\9M1O-*[F!1SBHPZJ"M#.W2(D'9X*>2%03`^L*M17_C=%:1D?UD=]NP59\I-J\NX'?+ESE+4X%X0,V MGQ,A%Z,4WD=VS=E7S(<819C+B>8@PH@3.AWQ*:+D/\4LFDBY:WH17V=6IP!Z:/%_BX)I1P&1*/>K+ MN,P,(IGF&>`K4;`.@%'.:F#K0@+9GY=3H,/%PI"1" M9?>_8M$*!I][0O$H'$"H0&04G3D(Q'"88U$R="-1%RW?2`%%A5-9A"'F9`46 M6&&K=F$N[B)%M:`5+4XE$W)`S5%3^T;?M;;!QA=.Y0=V^TQCAL!4V#4&3%@5 M$TZE"K0-M"9A4R/A&B>U@!4Q3D7E.:PPHE5OCM+W314B;5-CU$33BVVY<6J5 MW(J-2ON_ZI)1ECU.P%3M8=*6:L55ZIU#BU4YB5,)`9DX8M1H^'(11ZU>!JI, M[E0&X"J`^7\"8XP(3/\':$%B%.70ZQ(R%D*.TF(#71'E5#9@@F,$(5MP@SB% M\$U`P+:<2]OB8(A#XA/=Q,-&R%&B;*`KHIS:S&AREL+$>BL_ZG(/K$S)=":5=?>C>V]D7?]A6^9KS M#-F>^0N[/?/;RCP6>MOJW-L]_Y&#;XTY"[4]8^'IJT^&T[69%:9+K-_]4BK1 MBM=K3+AQ\%V`:FNN4TF3`1/0MWQD+$B:+>8KXF/Q`.U2.[6L+NR:^4U8%1/5 M29-N&_FKM*N@TVW'KTM)TJYQR'@6>D/$C<4G0AE/+C-(U_V!N6(M:?#Z"<3FT?`3Z-*9"=Y^WXK@[CMF=Y1:X5A4ZE53:: M99YV#6&D/LU<6=)56C50%075*8HV!@[-8I)A2K@B;8H/IW(2 M-@M\8QC>9//V.48"#W'ZMVK[XIZ5N:+X+?2`9$K33:7^^I$C*I"?1W$YH?[%*%+::O8BC5-NO34@[W-X<87AF@/M/S[1:Y#4IU["_WR MQAR`-^9L1>#UU^LO0AYDV:1,KJ!%KZH.)S01_G^DH)U2-C1^S:S&J;UVX)5VUD^,XKG MBXBM,58[6W)3,\/.@'UK.EEZ&^JI[I-S:H^6NJW'/JE2*W%B?-;JHWAS*H^9 MGJG/=?ZC4"DR``>=ZC<;60B=&'LV*BD"G7A(4^C$"-*I MH`AQ:]O5][L6MC=YC1?'WE:G15O:DU'(D-S1\@W'^G4#"[$3X]).*<5C=0K- M#1[5Q<&9<7;@*U8VQ4Y>>)V%5+<.;>5;0=W,LW: M:&R^<:21],DS:M!-D>M4-J9Z&,AN"VPT'FYD3I['DD:*/:?2-5K<._>JV1)8 M$OL>."PII>Z9=RKKHO\M&^NEYV;B[2QX[J%A;FW"VB44O4XE9RH42+=6[;DF MIA5NX49_'^,@V30FSZ".0O.O^NA2&HVK<*E;,E"8^W6`A@HJ'W8L/[5.8OQ' M=N5#`Y8;"HN7ZVO35;4RIT9FO4:*/;[C&RHT=NU-JH;0*[QF=/F(^SR[$NI?M=O04D6FZI5_CQXVD3XGQIKHI M;MU*H6TWKRF&JTW)M3M@@1@#W M7W)_)AT]-%\%:"-T8C3;J*08/-9ARHK1^TZ(I?R)ZL+;87CY)^(<:8YAV\F< M$A]V&JG?'CQ2BJWRES*W`__-"^8^D7XQ2MXE:EBQESTU=NPU4RS59\J^@V!& M:SIE`:?R+.EX-0IO7J"GHU,\03$>4;U)-"-`,_&3H[>9>HK@^GU%FI,?\*U4 M9X+#@DD$F2^VBV)5/53^A[0`&D1UF^?G\O.]UO2$1?L3$DF/X)U]+>8LG7 M]#[387^+/TBOX^M1^$"FE(3$E^F;=`T/FOV81<1/&KVEU6VK^R:6MWUYR?H7 MN];/:DH.3&WK\K:5>:JVPQG(!]W6=BX*?1-K%E]1LMGEKLUD^>2451[4`8ZI M.?]FZX06OX!P'(>K/:,'AGI3SRS5<;H.=.]U9JN M^X32@WXEH#U9@7P*__P74$L#!!0````(`':"KT!C:3]EC`4``-HI```5`!P` M;&9V;BTR,#$R,#,S,5]D968N>&UL550)``-?NK)/7[JR3W5X"P`!!"4.```$ M.0$``-5:76_;-A1]'[#_P*D/2X#*\D>S-$'=PK6S+4"R!$ZZ]:V@)=KF2I$> M224VBO[W75*2%=E2;*=VK#Q%D2XO#\^Y'Z2L=Q^F(4-W1"HJ>-MIU.H.(MP7 M`>6CMA,I%RN?4N?#^Y]_>O>+ZZ+/'_L7Z`_"B<2:!.B>ZK&]=XGE5]05DYFD MH[%&!]U#-)BA?A_U!.>$,3)#KILZ^8@5C!4\]M:L-9)GC/*O`WB&`!-7;6>L M]>34\^[O[VO3@60U(4=>LUYO>:FA$UN>3A7-6=^W4MN&]_GRXL8?DQ"[E"N- MN9^-,FZ*QC5.3DX\^Q1,%3U5=OR%\+&V+*W$A4HMS']N:N::6VZCZ;8:M:D* MYKC`)M#S:1XZ./+BAXZA2PI&^F2(+-)3/9N0MJ-H.&%FA?;>6))AVV'#.PY3 M-9KU5CS1JY[PHY!PW>'!&==4S\[Y4,C0+L]!QN^G_OD<`*-#@H,[S#4>D9HO M0L]8>(\[\0S"@`PII^;&!<#)`25337A`@A2JJ3:.ZG7DHM3^X27F M`8H'HV6\6/KKDEJB<"J0D?;(':`]Q[M",\8 M7$@_&A`7)B5[PSB=Q(9IPQ/1F:`N&/PM6$6*Z(;'+HW>(U,[@ MAB0<$+DAS/S0&./3:]&-ADYB4E-=#6^T\+^.!0N@'YW]%T&2KEV-5KDQ^;W] MBK1JUGQ-:D$AFH^`ZZZ`^;CIA7"E!*.!;:J94R2&Z*';7U'LV%:QK@@GDHQ- MR-P1*&8`BJ"#3QQ'`04WA[9',.'G%LE,$Q.R,&JLXD.L!E9VZ/TCC"<0/HV& M1YA6Z1TC7\.M-Y*N]2JY_64.^Q8/,MD9'A!FYUTR\/8%$*0GYW"I'@/YP&BA MEW5D'C(D1NHHR9$UBWP\9BA%6#YW,I$HIE!("(NV4VL='X&IS?%3GPD(J;:C M942RFX)K"/`S9D=#;I*1N7#01%(A(:1@[Y?D[QC+P_\]<=65)$-5I"(=+0/D6[&6!)UKE24G?T>;B)S MCY^?ZC4.!3F$\^)^#*TS4@!`3.)2M(\35]F1.+=++SZM5X[F`IP9VFB&!LZJ:Q8&ZYC7H2.6S\@YO(; M+G.G#%"FOY>DWII+RL0[>KIX.ZVD<1CVB=*2^K"IL6:=>RR#OXB^&OXNY)!0 M'8'-^H5U$Y^5$WT[R\J$_ZW2/72[PF_@\@7IOL&J,MF/JR%[GTPBZ8_-OF`Y ME,N$73&HLM*MP)V)\[;2XMAXVU";9,Q+DR:!G2ESLG=E.L&_D=+VE\I;4?+* M*^GTI=5%&X!8L9NR8L@+__E2?HIY+=K:+@<@D!3'S/4PQJC@V_J1DC=%0'YWECX M9.2;LC\:WYHO2KX?OD9TB#"??4]^BY]_@`C__`]02P,$%`````@`=H*O0%*Q MP>CS)```20$"`!4`'`!L9G9N+3(P,3(P,S,Q7VQA8BYX;6Q55`D``U^ZLD]? MNK)/=7@+``$$)0X```0Y`0``Y5WK;]PXDO]^P/T/O.P!FP#M)$[V]BZ#G5ET M_)CUK9/VV9Y]8#`8J"6VK8M:ZI74CGO_^N-#4E,MOO1H%H/[,)C89I5^15:1 M++)8]8<_/J\3](3S(L[2[U^Y3D']!9]EFE\?8*+7?H]A:= M9VF*DP3OT,E)S>1C4!#:+.7[-FZ]? MO[Y^7N;)ZRQ_>//N[=OW;^J&+WC+[YZ+N-7ZZ_NZ[>F;OWVZO@L?\3HXB=.B M#-)P3T79R.A./WSX\(;]E30MXN\*1G^=A4')>LF("RE;T)].ZF8G]%_*W<;_/V+(EYO$@J;_>XQQRLYAB3/WU#Z-RE^ MH,-#^7^@_$]_3_G_IOKU=;#$R0M$6_YT>Z44YT.+5T7TQA'&^ZP,DD%`14J* MENH5_>F:X&HAQL\E3B,KI_37 M\RS5KK)\S;1IOBS*/`C+=L]1,M(SI^_>ON>Z\9L>C-@8 ML>_/\S;&(`_K[Y!_&@2N6KP),V(SF_(DX7W*R5=YMAX@79GU(/HU62:B-"U1 M&P9TIEP/ M?VAH9HA3H3T9T2E"V.@39@6^UBB"#$)' M`^9W=Q?W=_OA=J"@=KA8(^GRYUX?S[9Y3O<#-FK9:0NEG0K0724]:`BHJU(D M'=6H6J&`T0"HKAU,WG:&:KC0JGP6%(]D1TO_1Z?]IR!A>XCR+,CS'7'7_Q(D MV\/M<$]:]ZK>2RA1]:T(>WD0$UE"#V!=RR!$S)$(Z3_PGMRID4PB`?N'0#Y# M08EJ#HBQ`-NC/`4Q^7*"+[/\CJ"[P^$VC\L8%^=X6>Y_J@Q?-97TY0*PC@P3 MM+7"]&,!87"#('84EQY@XI*R045#0I2V9HZ(2X\*PM[M>C6);`V7$R+$"14" MW0DR4E:M7U3G67D;@OA5P$RIP,[A*G\C7LWQ'P"C$;3=QK^8RB*):BW^' M4./N]SO#WS1QJJ=]@#%MA%+"<[S"Q`JB^^"9^T/&J5A+X5Y%+000-5;3'$*! MC7"4SG544:(X#;,U1F7PS!UNIWK>'W]-@0@)JEWP<=.QXC+M)L>;((XNGC7+.IFTZNS3(UL,+048&*`-44S)^L:297 M7XT5CH./1?C1L>!'U?TCNVV0!HN4&5IBLCT,DOB?;&)BQQPS5&1) M-$/$O2**7Q!A>%@)^7.68K3#08Y>DC_2CZ;T6C5!V8:&GU!OVW/3).-;XAQ` M.0$/Z6U.;L$/Y8V'\2!.6Q=`9_Q9=`P*/3F!MSMYGR&&^AC&)<0*':E+(2SI M,]'F'C=>LN90]J6&WC6U;EO`JR\5F(ZZ7).%ZH3,ZFLXZ[/&VNR_&P+P6["; MG*[^Y>Z&`&4!7O_8QANZ`5*?DNA)W&NZC0BBMNO:0ZPS9CR2;0Y[>7`/!LYC).XQ)?QT\XNB(.0/H0D[UNXV8K>L!$Y-X<[,00 M#4)/`6$2-H@D)WQURVHI<&\/@W!SHA-&A00AA-,:GXXK]XM7CT,JD7AX@TFR-_SR^-0JB/,/>D<`;"7?W#C:!2?E5S"*/00V^;@[PM MC"'HL$BTYT@GA7H]'X01=1T$ET=@D_4PA).N]=#@''"UNPUWI*4Z>%GW+W-M17 M--'*;&E!#KGZ@>ONZZ[F'Z^NK^ZO+N[0_/,YNKM?G/WY3XOK\XO;N]^BB__Y MZ>K^[^CE^<7EU=G5_2NGQCQ6LCUY?8%Y^B5+QY*^0*JZHQ7:R$,);7.#\J7Z<4=SB3PTD$7&Y5FT#/P?;5"%T?$PP**)`J3?X*%VM-&&"/48$,ZOP4[EPC#?XNACEFX+X]L_>5N0 MS:,:],'>L=L0:.NH`B+;C]&V:,D;N]XX]L99-0;?-BZ(1>45J*YOIQ#81.1> MN>W$$+5<3P&A[C:(.OK$B%!0:54=JNM4_4?@KJU!=D@`:A']3,$C&^BA_!YI M?4^U"8$/P89@GD;%E<[%4Y8\$>?E.D[Q8G66XRBF,6N5?5VE)29]<*C#_4B= MNQ^]1!+\$2LZEPY*#T"2+71%C2@YW3IS!LQEK:?/F@>`%S.-;$DE6[B7K5[2 MXF/)9N'JC!'NK/T>"E4>COPMU#++\^PK:5T@:@(HJ'J"^$T9FSV(AY22WRZ# M],L,I5F)<%+@K^0OA!/QE>)5S%])T4^4P3-]N[2;\92[`5H')96IYHIA;CNZ^?JY']I1G:^J")IOFEK\)H1DS&),++ M!"*,RBQ".Y1*W1XFG,J$I_NB\3'+RSJLL*8&VV@,$&!/8K'E MF";*Q!QS=-RW.Y2',):K96C_8K.GYOP'C?@@#%?4W8SF.U9 M/ULTT(!:I-T#1BT!=-#*@*>,'MBK/6K1=#UZV7AX`&$,SM<1P)]4Z0/TU:U] M.*\RAI#SXY\$7/\'`E>8@%=>E<7;%`.5)[Z5Z:6*EL0;#\OB586?GE4?X%9V M`>A?C1X$L+V=>?T&WK<9=FG`OI-V-^_!YLMFJ^6#<]2_'P$"/DMZ@LUBXK*4 MGMSB-%1;D)8"*&A3+T`G+%/>'"SP4@=''HK(*7CB=I'&?9#E*.QG_+EV2.OWH^?1(+?LKPNY0Z]C/`J#N/2[3.ND=BK9UOSLLSCY;:L M0XIO`B^.!F[R*J4``ZTK]"%M"9'B2`FXG=FHTPPFH9$"ABQ]8I7;H:!-T0G: M!'EU1_KO;U^_?7N*-L2_+AZ)WLS0?[R=O7W+_N._(=/LMGS,UI*^'5Q-!F9!)+;5DJ2GACTR,SV=]L;WZ`YC)8ALJ""#VU?V,JB' M1[5B&ZCSV2X&Z<%FEEJYZ.]T/CH[%3U]^V'V[O3#[/WO3]G/'_YK]I\??C?[ MW8M&G_Q\`7E/)]^*$M3R^KCW%F3`]MG3*19-%LJK'XW>9W]>$,[2F==2 M@%J*C1NO:0YL&9;.;]LB8+WWP>A]\]L[@FB==F5K#[1?[:XKFGJA]5IG5ZKQ M`%[Z(-0M3?=HFV3KG>M)/%!X@U^N:^^%ZIM]6:G^0[GCP_$?6(('GO@\BF+Z M(#A(;H(XNDK/@DU0I?<,^#\/M>IM0E^:L2&T+W-V(LCVHR9"L)F;%')\E35#5$5I.746`8#KPE138E>BK*<=P+.G*>. MJ[&P]S7$?CH^>%9-)7VY@*2;&R+H02*Z/BR` M4M3UAZ@U-I[O(Q3YH(2P<)W1;F*Q^&.R%A_$&:&7E-4K5O:('H83?A"/:"!& M$CI<6M$5LH8^A$?+YHAN*XAI0(5"\7JD\#D6>GP,-.#[G2,-!-A;.&F9$87L M9C+_BMS(3-I$`_R^3H-)44+I&ZYHTZN2C1_O]MR-C^/EF^?;?L+I%JMK]G9: M`2S<YM.JLMQ=5\GS#(W)->X!,6B;PK41:JL8@+\@-:+KI MJ)KLQ'65@^_A*0[90-I.XN@5/QL@`M.K<;KM'@VW30MG&+"TP?GA"! MSO$33K(-S>^CMPP##42PAH40[3@-#0%,B(81D+2P'GLS1+4JVE,Y#M$8"5R@ M@K:%<[S)<1BS6B#DWPFF_Z"6OL[RLJH%JN@&.U*(!*/V(K6SC)KI8%*-VN*2 MI+K5\UG'X8?U]:S\?\!YTNAX&,KA]I)5)0K$EH-%U`4O-;M\,U/`.86BT.69- M84RN!\Q6$"&HR8WH6[?&]CE+LS;H:K8PG'Q;T+DW1&MA1+,T$H&I6'8UVJM`]L4K/+\:!_,!!IOB!AI,[Z5?'A_-!G-+ETM:D`/\7MBZ(3&/Y"=,'S"N@KC.M,0*O8(7 MA!DI&26O-J&TC*U07$5@PB+U9H@S@CBG`1H^3[:W?;VUC(:8&`QC5 M$41K[YJTG3C(?>N0_2K@P<\1>M_U5KOVGB^)0?#Z(ELB3.4T9VGQ$:^RO'J* M=Q\\X^)3G&:TKGF]L9FG49L+C_W_A,O'C/SEB31ATYQR%^40`82+X+R#V^Z' ML\_#N#:.Q>O.3+AL6S):LB_6ORSI-QV[4-!]TCH<1-0>T!X&VN.HNZIZULC9 M(X'_K)[K&N2KRNJ@`2[J1?$KXZHL^QT/3=[MB5PZ7Q0O"@#8#+)@/9`>;YVZX99 M(FPOZ/+T`R#NU[@>=FM5=6:D.E/QQZ"(0X5@BK;NK4P+6K0V:4,(J],`L=@M M"8GGEY30J3GV@=[DV6KR5L_0QS9B6/4^CY-MJ4SL1)055=#U^F[.>'J-VJ^U]Q_/!(OC\G8Q4\X,_;]1+GBU4G$ZMNEN_) MP[UI#!)2-)A>#"#,:`#`CG;6/%#`F52)@2%6D$G%J9@@SH7>.'5+]P`O.@IY MJ[G!-K-V;R[>6*))4`M;5+'PR!KU$.WM$6*AFU@D.YL$7AMM,CF2E3RF!YIA MCH,"GV/^?U,2@`D8`P0M3]8=K1CGT5QA\@],!%L1CMG.^]G:\K)\4M1BRN#9 M<0Z#X\ILF=X5/*Q3U0V764ZFM_1LF^9`6!"5_R\1^2MCER3SZWRV_ M_=!W6L]1F/[S_DPQQ^I:FXEHZF^#O.!P*EO'OJO/H+#Z#BKWK%'0\/9B,G/4 M)1937MUK-10D8&%O'04T:`]'G0H;?HHTKQ23+ST^36/VXD^S0_)IJK%%VW]# MY,6T,5(\P-3VQA=J@`/J.AMI1TA#)0TM!4@I,Y,`!Y7,5,V!"IGIX7U$<:'O=U+((2TWW2/>U2A:R'C2#J5\A@MFM7B"TF-UB=OLL^ M+2GY4#5"/[-FOW@PYM=QBEFXI4DPH2'@V'?@2L>_:06C`P>?U^D!;GF?,#U[5L]VA^U`2Y.VP2KJD?)&3M5`\75MR4ZP&@CF0LS0U9=-)9>/ M6F=YPW;QQ%[S4K<1L"A5_#$@/X:XKBWK-O6H-;PC[*)LN]"VQ(@4*7@]6^W, M::#QIHJM>D;5$CB=72V0&.N]7C7U7GVI\*I5'U5C^$JN:H61MW2J*3H(VCJ# MYX?E61W/,.;"B?K9QI[>RRJFFEG(EMCMC-0/U<"JGF]D";D@E*1C8P\AW_PU MR/,@+0L4,Z9HE>6HJ,K[N*_%.85DC!'BG!!GA3BO&6+<9CQ8ZV1)&2*18W-V M>9GE*QR7VWS(*\UD]912TWSW]GUEF/0W*@'Y?I_]L1J3>1K5HW+QC/,P+CK^ MWA0,W1GJ=.)3@QW/S6'G#?'+;UDQ>1^N*^N_4 M9#-!W*\5_=$<^"@+6=(@V>+ID;3'F;'XE#S=A&7)SX_YJI?PING*BAGX;-4# M99_)BK']IN:J,1UA,EYOIB@W0GKA$/'9^!8791Z']!D`;38G8"-V,RQL`OOM M6?OP]<9=ZM\9%MZ3/5./G*F^H+O))`A+>NQ-S2!OV*""\H&Y4SB2H#I7ZZYZ M[;-G7\WU[`/3>%K'/RZ9?G+HP=:;N:%W5]@>K'QC,T-/S+TF!A\FA+'R61R] M?"/3P2W>D/Y^I"=$W1E3UZD&0B"3MA*G8[1:*C"SM$`EJ;Q6TU`EH[&[0;J# M7I"'",)M1J"4+[LP*;?<#(\_LP&;T@;T147GUUS0$L9V*F!$OLT$`J@^FN;- M!*##;[1_1NR?^8\>$]>!0_5SM.(^4T2Q5(#4KM-RAEY0;F?Y>224%3^HA3-LT$3M!S]ZIW&=DJ2(_QPEN)6F] MSZ:Q\.-_%G0[=-2N5.R>CO)-D+G&C5"F'4Q>?XSE':KS[V?L)XH);00KWU>W M"8!F,?A.XZ4<:,]4E1U(9S4?1]T\U.3/W]ILV2\(UI]`5_M@5G\"5ON';O*X MS%!H3G4,KS=)ML,0K[&LX2O"2D$?##+P/V991`,YB&77_7A7!?D*67GTE>(& M:LQ:K&>T8L_D%Y@V]#")2.S4J<3MHU+158>C4+5%T'1:#A57AD%7:/6$^>%S7K<>'>PX'"FX-ES8\B=,3VO0HI1_M;Z'_7U3Y M/DQ5*!SY5-=SAH/;/@Q`"CWV%.^@]J,E-(H;+ZBE=]9P-G]\48(>CI@AWN-RW*]=\;LO28U!Q\F":.`!F=< M1>['U&&`IS8[ZHZS2'.4E!=2=Z4=_V]M0X<1M.[8F[K9?%Y&O?',KB@>7D6[)^#UBI M9*2>V(]")*,)'=!Y8T527-K5*.!$S7X)WGIZRM`Q(":.V01A3PTQ3?1%9_?011:P[>D[GNG>[T`4I((8/B_F%GKD5TSQ MD%#+R)NYQD)U(T/Y#$Y;W3D0<%V/#)U$5V^^7NAF`O MYVE$DXIL:!/;WM`P\&`J,(JGG1.4U%Y,#@9T6H7$=5O8V:&W"))IHN8Q0XS+ MC%WI7G3E`YTS)AXK7WWPT=Z0WS[W.%_;H_,])3JU_UFYG%*/TU/7>CJ7VJ.S MO:,-G1=SRF6EI$WOU%,TQ" M,DE'G.LIBC/1AVS53F61BFXG#W;M]<7]-WWGX[* M-AVQ2S9UEVQ:_9$W_9%4_1'N^Z.^XH^/U1_&$D_?3(>XW;_K- M:BZ<='.^>9?)?KCL/?+;"ZFMJHQ6U1VQ59I'5Y.HMZH"7[>B)D9YNM MUUG* MZSC#,O)TJZZ4V,(C5"*6>;MF&L>G4[9"-*=/)@)WITMV2+0%+D4-;Q7V=GXN M-($P(1>F:(2!J]OM1IJ1]BL>-M55P1>K;D5QF8#VM([MN:]0C5W;$KJS[WZ( M#$&38MGWA5#V'EKI'?%T=\,>!:@<=?CK--&3B=6R80 MIT:_0C431+G4XK!%G?U#8`7Q2-[ER+F=5N0R\"+'AZD!%)W3CX7[:66(B.*T MTH<>8EKICT^;R4%I>&ZCVR:02BG)K"HOCB2I.2!V+P`C.)EPO%3P71GD97\1 MYV37EN<[LL/2%517RH-.T!(_Q&E*MVAD$>%8H.HA'TM$G$8JX=RN$S3ZM2[B MV$1^IY%DDWT>%V&2%=L<&R*FQ[.%64^FZ(K#-68,3Y#8ZFE`RVJ%<#/8OQ&@ ME@$?<'TD>9O(9^I[YUM"!R?:UO!;PZS MM:W=G6!;P.AJ3D/#ZRTM2U:]5GH5Z^BH>KP8426&>*GC_H1ZO!Q)$Z:HEVA2 M6ZV+^O2T6`49J-UJ15%8KY0&RH8U8(R6W!1G\LN>AXL4M43RR;:/*Y/;7?K= M=K-),!,^J7L,PR;<6MJ@`K(_01K53RV(P790??"UBWW^]/-S?7% MIXO/]_-K='YU=W:]N/OI]@(M+M'9_.Y/Z/)Z\5=T]?ER4BC&](W]2YNL:K.0(+DCOR&+0S" M`:+X M$;?GDP"BSU#K0ZPGQ$_1#FD^AO9?:QU?T@\B]L5?OLF)R.!63<3[&YMR="[9 M)(Q!'+8)D0^=4A2.C]^SRQ%%=WS"$C^D\2H.:>H\7@$G3A]N2%^$,2Y,^Q!; M8H#SE5YBM8Y7K"@A=@)]D$D.(-;K(-]1%13XH#TC5'-RN\:/$THOB1Y>3O/YSO!?MQ.!R:=$1Y=OPW&[OU2;`JO;E49$?!F$M-;9SK#6Z$G< MKS8V(HCKC:X]R(IC!F0T4)AEY3C`'?LR]*KZ,4LBG! MP*/I*US+J;$E!O%K^H'K;G`$^M\BSL&M#W,$`1!EX=NI(H=F6%,.&P&\NY/" M;+VL:[4`62ED$.PT`VB%F!:P6\7=VQ'+RM%DP[K%"4W#-B3I"M*61+"%6G$D@RW5?FW?.@94>1S1A'>*9@QJ^J&*,&.=9*_E> MDU[+A[7+NF.68L<8UKJQ3#V>`+3=,,C^I1Q!UMXI(%N;/]1Z#2^DV<`KR!&. M?YV3ST<4PF42/*@G@`*'KQ^RIS>$A-L^^<>AR4O8N3,TI2S49CI_[+7ZJ7I+ M/E:]U>B'ABFB7.VC4`54ET+TC^CH/\(HW.B;J-'U`U9[=C:Y*P'F95 MNZ$CKN_&#Z2"K=L1U$?YC MQGW_9HQM#HO%MBS*((WB=()=F>E=B!?&C:`&E5.VAGIQK`3> M?7G<:>I6E[0@;-5'>'7'"AK@G-<@]$"1!%OI!@79SV0Z6M"IS"R48BY3$X)- M9B9(P]11&@!#7X#1.DPY?B0,:'Z=ZL6Z5QI;9S4Q77KK24#U4RF"0BT[[<&T M48%DF!(V"6:4Q0``/8Y`0`5`!P`;&9V;BTR,#$R,#,S,5]P&UL550)``-?NK)/7[JR M3W5X"P`!!"4.```$.0$``.U=W7/;N!%_[TS_!]9]Z-V#/V3GDB;3M"/;\8VG M3J21??UXNH$I2$)#`2I(*5;_^@(D05(D`((6)8+(/<61L-#N_A:+Q0)8_.5O M+\O`VT`:(H(_G@S.+DX\B'TR17C^\60=GH+01^CD;W_]_>_^\H?34^]?UY,' M[V>((041G'K?4+2(/_L,Z%?OAJRV%,T7D??#S8_>\]:;3+Q;@C$,`KCU3D]% M)]<@9+0$)[U=G@W2[P*$OSZS[SS&$PX_O(3HX\DBBE8?SL^_??MV]NWJC-#Y M^>7%Q>#\7Y\?'OT%7()3A,,(8!^>>*S]AS#^\('X((H%*I"_/--`='!UGOV6 ML@7_WZEH=LH_.AU`$ MSCS^[R^3^XPB0#,(IAN`(S"'9SY9GO,6Y[?$7R\ACH9X^@E'*-K>XQFARUAZ M]M.\VP_1=@4_GH1HN0J@^&Q!X>SC23#;8";9X/+B*I'KC_K^SHL<-N]\1.<` MH__%G;$?8&:`PM%L3&'(?C']"4.Y3;K:D]O']7()Z'8T>T1SC&;(9SP,?9^L MF5[P?$P"Y",8&G-LVMV>7#\@#$>S&PJG*#+F;9=H7[U%Q/^Z(,&4.95/_UTS M&S+7D82T#6YBAW-#EBN(PV9VIB*/N5H5S(VI\&O*"B=L9=RBB'=T<>&=>J)] M\4^`IUY"["E'/7R)()[":>Q;`N+O?!EP-TEHG0KY)[_J&!X^AQ$%?B0Z"L`S M#)*>#.G.C=E+U1H[VQ#Z9W.R.9]"Q)SN8,#_X*P/3B\&J:/^(_LHX^&)=5OB ML?IU!=DAW64+4%]TPO[<`;LZ#:0MSE>`LOY._04*IH)Z1LFRD992+HB,;4+9 MH/EX\M/9Q=6)MPX93V3%J4%P:.T.&1-3SLA=`.82]9:^[XU^2WSG"O[IR`H6 MS(\A183Q/[UEL9?&CDOM>J-P!?^YXM\<6?$)YQ,X1YQA''T!2YG>Y=@(5$R3I/0X(Y]%FH"($G; MWJ"AD2'W2^\Z!8$[2S,("BU["D!!@ES];^7J/R_G`_;+7%R#@.H*U+JL6"D?U2!75C+IW>38P#OU,F[8WS>$=8_Y M_@+[*R0!FL8;%6D?7M*)]\,O&*RGB'WSHWEFK.@Y9R!\CMW1.CR=`[!*W"<, MHE!\4O:CZ<>_9LR.9G<(,Z80<_,D1+I$&O$-R5XW#;Q>F&$8,G5JV"XW./HT M8*RZ?!:0\9TZ_\%9Q?4S86:0+26F#XG42F9C3C>0/I,0QFTY+2*4C6;6,5>- MYW6!7KH0J@6QTJX++.4&MXM:A=$4O,NS:BJCQ^AQO\L"&_X/GQ,V(.#^>!C= M`$JW+&K_!PC6Y;4[5Y(A77?H*@Q2@&S(?PKZ%=_1KH!>`&X?"SBZN]T`Q)`, MX!VACTSN1^BOF2`(AK?P.,-D(W3)!)3CN?FTM;KMLICB]=0FGVY35 M)_"2:$0[_+2MK451RW4*ZCL[0%6<71A3N`)H^NF%'^"`(0L>;N&*+P#*&:S: MUG:"5,=U"M*?VP4I@K2[>:^HD[H5BZVP5?E,@7K?,E`D`D&G0'TAV#=<9@FX=@KRC!2 M+1+8C'`=[P)AIS)#(M@K*TF*K:JIW:BJN!9XMIS8Z3Z\5<9(]D9$.1HMIV.Z MC&$?$'A&09Q,9`%!=2]6$].:D_9E8\Q<(F$);]V*A`L*J-\YTS7N`O&FIBQ! M7;6[-GAW5CV[UV.<1=)Y#+8\XUR?5"\W[!A?PYQZF6N!9LO)HFZC(WZX$87\ MBJN0]XE<4_(5TEL(`F;]?#\Q@(`B/"_>+)1-P7OT9;=%["&8,)J6$UX&Q4PFH6&AS<'N*J@Y.2[)-RJEQ0X(- MF]@?"I4`V'R?VND]CB#3O/2"MS&IQ0`VDD,@ZM1!HEM(T8:ALH%&HU3?W&*D M:WD7Z+:=O^HPFVB$:/]PU*'7\B$C2[*/1MOH->U[FG72;+5?OG,KP5@.);2; M.;K&'4-=OZ>C8UZ`ZU0>2CKUU&S6U5!8#W*M!`+IMD\]V3'CZCUTY_B]UA_G M]RM:3BIU.=7&&=`HOM;([94\Z=3;4&HL6(]E5UV(D[;J9C_>%$LIRP)$2U)-[?GDM"Z)\D)C MI8G=X%7Y%<@YE5(:3JWX`58G-[07K9;HT!D=WHFD@@\';JSMH$ M1@!A./T$*&8!1#CT_?5R'?#R"[=PAGPDFUQ-B.S&VT0"@;=3=]\*@L8+>5X@ ME\(%Q"%;Z]UCGRSA`PGYZ=O1[`F\R+=FF_5@MR4T%D>81.+]5GFIK:4MT^R(QHQ.XR7%&-*XBF/M:E=-V)<#Z:;RY*MC MAQ)9N\(GA3N'ZVC!I/E?[@F4Z%<)^HEZ58X<;=FA=(?0O@_#M3'2HG&?418R MY`A7'SQP"F%U*6*5BKJM0]PBUK(:Q`SP:@WBW@)>2`LUF,.-J/H"O)$P>8;4 MH=F[4G-;.W5K6_<0;/6D_<:E2;LBL7+&5K;L+;CEN?J-2W-U@S<#I,KIY2QM M]$P`P_G04_1QTB.J"N&[J9%+L\Q(WIE'9E[>79?%J).L=,:9)@NB;'GT#'-R MM6T#\1K*R]-46G0QN&HTFR66R[QFA:8=VBFZ(2'S,3\3,HVSJI!ND`_#1Q+( M9T%U8XN!U+&=U9]V9IOG9TK"<$S)3+JIN_.MQ9CM\'F8>M%=[N:D4PR>9T4A MU>Y=T]9B`#5<9]6>G;H;\`@#UN><>1C^X#8LB"Z;!S6-NP"UUAZS25'#N(O5 MGI/WU`-^V7"Z1#A^AY$?F%=#6TMA-;ZUW+M8*IH79V!Z7,25>3VM!KB&=[N*1K=6@(]"MH+F@K"_`QACPBQ\26B45DJ1H&Q&9C789B*X5X.Z MHB"3L,IR+"7\NE>3.A,R/Y.G@Z[8J@^Q<)'?O!JU,^A](9CLBIK:JF9U8T!C M,;(&W.=UJ9U:[HBB&^HHJ=*B"QR-33)_&*7$==M5I]\G8&(XYZGGKI8U`&'N MAD8XOP-\CYE&XO=5^3GH,861]&2X.6DO\#87YT#%J;N,DY3::N*H>P*TAO]# ME:GN<"K.(XT[IK+DXO":5X?,]K:NX8S0].[#$WB!X6>$8TF%!V3KA-U>DG/6 MGV&T(%/^?E287$Q6[D@=Z=DF'ZC7$4+ZOH6QIO75(>,[+ M;U.V[!&2&<^65;QN!\M_0C1?,/&&C`TPAU_6RV=(1[/*02_52&U( M;S'N#25QLL"V0@?I$#`Y\MBXA_Y9A%H6=VMUU]QK9[X2\56#3R$(X2U,_M6= M/6FA4XLMIPWQ\J+@3N5W5:JY8\M5-,=)65=_^T0!#ID>DGW%^']!`O+T/^MD M::I79`.C:_^G.]GP:VV+*T,W&Q&R"\2#=N\/K^)@DO%"H]_*Y;4" MFKI@VJ#=*\'=0Z>H\ZKTCS7MK?65-7QG\/[D@-\LUW)5@JEJ:"V**H8S^-XZ M`)]!`5;U\#2GM1;D!C)DN+]S`/=XVDE"A=LU?YXXR1+%)83$!CR<LNO5"H$2T+%^,M1S#6_@?]/0"G`4?CI!5(?A=4XN(4. M+82_!:FRB_!65-IJ9@J)C;=G"8;]]7 MI^I-0'YORJDK-PUV=W^]M!6G,I=9F9G+0:MKQ62C\!/N-`ILOL-K,7!27@OP MM5J[O0:^@QPG*NVUA,,7I#U9I&M?LB\II-E>3-7P#P2N_@Q2O3RQX1T0"NUN M5_%*H797K(GJJT9[(-5KE4N,QF\WN<500;LE!WDSQJJ*F1]8I..C[% MJD2J$`PVEDGC$GI\TZH'L?WKK5@?^UNRI]UZPND+P3[35QRD/9$)]-G_40!W ME/!$]G<,A__)?EK;X?6BW8GOK2MRKE+NL<;DJPKNNK5S9GR8RZ(#6\-ZZ6 MXGNPH5HEN+BE$F](%>?ET4SHX8:-J;F\:+P!T?=@,29Z<'%_)]DP_SOB13F3 M^IP2(Y$U^AZ,0B;W89XHZ/A-(%>+9Q_;8)K7WFZKBIL5)Y3*1Q<*NDN/Y.@? M_30F_AYLJ8D^G'V2H:R"H>^3-4.`Z1RR\26O?V%&UE&=FH8#1&T-,IF]"(=J!W$[I=HZ@GP#'8-@X$,IJ^FT%%H+:? M6K`7?+IFO#=T"#(R!TR@(M.AGG#H\FDGXTWTO0X<]?6$0!,)#_0X1*O".4?_(( M_36-E7$+GZ69\,9=6.1-#`9#EOEN+*>3SU*PJ$I<,?3_NT;\7;,(X#EB:AB& M(90^%6=`TU.;J!>L[7X5*#G&"P,3.\0!MC?,S#5=M+3P%0K4_[R@B6! MJ:)B&-_H3=WB"!=CJ0G#Y$Z3+-'?TP!-#H^<`S9,W>24>I1%U#PVGJ8C" M1)QZH=:D2`H_'#F;03^*EWJF9]Y;Z[F?IM6:^,+LVLK36F%VPEO?$9I7:6+^ M.7\(0;-0TA'UTUA,)!-VT%9&=D\[4(0UO((&DWJ7^4)!3UG84D_30U3-!!.@ M6G)65`%J,:(2%5E'LVJU5AFXYK0]!=E<0'%_TJG\I[D&]UJT]M(\&DHH[*/E M1W^Z3&TDX`]>>:01N>WIC&;2 M"&MHN5Y`E_OS%_]>!(P;`!1$FT')NLNM2A$)!XJI,MMN#IY+PZ!:%?D#" M-:T\"5ZRC?VZ[(/1[">AL*:WEF^0W!`F&PW3>[;/T1/19(<,"+I`MBT3SQ:; M-3(*;"VYM&Z$K+@$V1!?!9F#*"LD%5@[==?\<;U:!;$O!(%0ZSV>$;I,P-24 M0#2E[+V%-!%6&(ECQS3%OBW?39$>ZB]^W@5@"7>!88MY_0D&!ZG\.Z(S@%.ZY\P[W4-0A2.9N/"SV0J2:OPOKVX M&'BG7N[4V'^*O7@`3[VX'UY^M]C3AV-7W2VRE9<(3B0M,C::I5X;!'GQ8,W< MU%*_1Z\6M`_;.=Y/S,ZN`_F6;OL_T86S:-5NLG)#K:LF*R7LABMZ7"^7@&Y' MLT:9%B]\H!HFG8Q8`PT6"6UE#P[=@04+^P4Q@(;RI3 M4('J3UY*=^S-^OA7-0.@W*#[QXN^D`B:19H-:+L82'+=JQ\Y4C+OXFA2'C'E#PBB,S_[&K(J3H)I1N&^' M1R]0;,KO=9%?W5C>N\4_>?WO_L_4$L#!!0` M```(`':"KT!]P7DW"08``#2;6P#I@:::7II'C*VM/MIOUUI M):UY^VX>!F0&4C'!>XUVL]4@P#WA,S[I-6+E4.4QUGAW\OS9VS\:<@]*2@'C=UMT3/<(32T/M*:4&M<^/CYV;6\J MKZF<@+ZD(:B(>K#4"=@8J#^C7-,)-#T1XFCMHU:GTRX;-Y[Q^CH00`AOI6NT711R4`HD\U:TOZ^: MJIF91CD7FFJ<\_8MBA@?"_-HXM>5(H!;5"'FX?/P?$L8C(0[$%YLO/^>^V=< M,[TX1S096OP&87ZOL57BQ/!(1O9AS#BS=K5:Q"&97O&1V_&G-#"+^F8* MH%7BZ7)3A6LQX9`;]`&DONT+[@,W20F?E`B8;[-;BD42,/+B,Z>QS[#GY6]O M7U.)Q*:@&8Z^P?7E_JHX'!P(\J(TT-,,S-*#ZFI\%9FM&0=,UT-%7T5`CNK% M(P_1(K>OM'"NYN*P,?#U=FW&//U>D0VR%1$IK-/9(KP?Y)D`+M_ M]$6(?I\B`)L!;B-(`'X'KQ"8/E73#X&XW["*\JZ*4+W:)U0&E5C8_U$<]HW$ ME9Q0SOZU(^&1">\+#!U_72"9A*6&7$6,WK3L(6#`E!<(%4O`ER*:7246SP2G MB-C]Q6.RY]J(PY#*!68L-N%X5_!0X+WGB1@/HGQRC9/:8Y`MEGJRU9$Y6HU, MBFA36HY)%?6J[/^@6@7CU$_GG=`1[OR1A4('I#PA<'?P-0M5!S= M8YJ<]I'3:3?GRC?&[69`SGHW M`S*]0PQ8*^O6LF%5RUAP;"QHO\DL('N84"Q*[V:&X)?[63*F:F2Q-M;5*XRP M!A0U)Y1&5M&%0*LEEI-C[6S,$O)P6TS+KJ:4OCGXP&J;LJIC'BH&-]^PT@\N M*OUTE;Y:@[:7^]^/E);42\_I)H5]K2>>Y$'[H:N+;7CK.=<0F@,"$HM1C.G8 M:'R4(HXR088BF)3L,R8K)OQ;"^/',CUWT72`7D/+&*$X"S`MFNR5O+O)\:-, M$#-Y1)E_-C<'+%!H^``BH5A6A;>TM@D5R82"@\;K76TZJR:NTTM2G,ZZ1DG] M&&G#R-R0W/60#7%KDC/S9>R&!J"&H&/)BVRJ!'X2$R^][&VD,A/!#.='\1*( MWL?K,@[BGW,-N!'K$K>:&H^/K#WPGRN%9@YBLRBN+=[-E*+%MO,JLK5II/,/ ME1+AU=D4^3"Z=,&!.*7%:75^H%ORQ5K?`7_3((;#^=>$>>!YD3N@_L2X M!'U-%TG-EE]+X0'XZH,4X>[+XW"HG^6?ZGQG0FUDT&H1HDDVQH7@%NA_7_3Q MT2M&*9NGY@/8ZAPN;5=U51X?W;[@Z6]XKL8#&.E;40A5@>-WY![A,BY;+-D, M$690CU^%].,+7S%]W,)D>`C.P``7^`!`!$`&````````0```*2!`````&QF=FXM M,C`Q,C`S,S$N>&UL550%``-?NK)/=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`=H*O0%EX%PT*#```;HT``!4`&````````0```*2!;CL``&QF=FXM,C`Q M,C`S,S%?8V%L+GAM;%54!0`#7[JR3W5X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`':"KT!C:3]EC`4``-HI```5`!@```````$```"D@<='``!L9G9N+3(P M,3(P,S,Q7V1E9BYX;6Q55`4``U^ZLD]U>`L``00E#@``!#D!``!02P$"'@,4 M````"`!V@J]`4K'!Z/,D``!)`0(`%0`8```````!````I(&B30``;&9V;BTR M,#$R,#,S,5]L86(N>&UL550%``-?NK)/=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`=H*O0&"E`@U[%```]CD!`!4`&````````0```*2!Y'(``&QF=FXM M,C`Q,C`S,S%?<')E+GAM;%54!0`#7[JR3W5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`':"KT!]P7DW"08``# XML 25 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Statements of Stockholders' Equity and Comprehensive Income (Unaudited) (USD $)

Total

Common Stock

Additional Paid In Capital

Accumulated Deficit

Accumulated Other Comprehensive Income/(Loss)

Balance at Jun. 30, 2011 $ (20,808,202) $ 98,795 $ 67,606,293 $ (88,453,607) $ (59,683)

Balance, shares at Jun. 30, 2011 98,794,499

Options/Warrants issued for services 880,891 880,891

Exercise of options and warrants 19,306,745 10,954 19,295,791

Exercise of options and warrants, shares 10,954,535

Issuance of restricted stock 149 (149)

Issuance of restricted stock, shares 149,253

Repurchase of company stock (976,073) (976,073)

Repurchase of company stock, shares (678,926)

Reclassification of liability warrants 16,478,071 16,478,071

Foreign currency translation adjustment 12,085 12,085

Net income (loss) 7,637,013 7,637,013

Balance at Mar. 31, 2012 $ 22,530,530 $ 109,898 $ 104,260,897 $ (81,792,667) $ (47,598)

Balance, shares at Mar. 31, 2012 109,219,361

X

- Definition

Exercise of options and warrants, shares

+ References

No definition available.

+ Details

Name: lfvn_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised

Namespace Prefix: lfvn_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Exercise of options and warrants

+ References

No definition available.

+ Details

Name: lfvn_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised

Namespace Prefix: lfvn_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Increase in additional paid in capital due to warrants issued during the period. Includes also the proceeds of debt securities issued with detachable stock purchase warrants that are allocable to the warrants. These warrants qualify for equity classification and provide the holder with a right to purchase stock from the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Warrant

-URI http://asc.fasb.org/extlink&oid=6528364

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 25

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6923874&loc=d3e4724-112606

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 14

-Paragraph 16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 24

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 19, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 13, 20, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4, 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph A240

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 1

-Section B

-Paragraph 11A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_StockRepurchasedDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 1

-Section B

-Paragraph 11A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_StockRepurchasedDuringPeriodValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 26 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

Stockholders' Equity
9 Months Ended

Mar. 31, 2012

Stockholders' Equity [Abstract]

Stockholders' Equity
Note 4 — Stockholders’ Equity

During the three and nine months ended March 31, 2012 we issued 8,571,884 and 9,405,035 shares of common stock, respectively, upon the exercise of warrants. During the three and nine months ended March 31, 2012 we issued 888,500 and 1,549,500 shares of common stock, respectively, upon the exercise of stock options. During the three and nine month periods ended March 31, 2012 we repurchased 228,926 and 678,926 shares of our common stock, respectively, at a total cost of $325,000 and $976,073, respectively. The cost of the shares is classified against our accumulated deficit as of March 31, 2012 as we have effectively retired these shares. During the three and nine months ended March 31, 2012 we issued 149,253 shares of restricted stock. The restricted stock vests in equal annual installments over four years

Our Articles of Incorporation authorize the issuance of preferred shares. However, as of March 31, 2012, none have been issued nor have any rights or preferences been assigned to the preferred shares by our Board of Directors.

In December 2011, certain outstanding warrants were amended removing price-based anti-dilution protection in exchange for a one month increase in the life of the warrants. As a result of this amendment, the warrants became classified as equity rather than a liability. In conjunction with the amendment, we marked the warrants to fair value, including the inducement, as of the date of the amendment, and then reclassified the liability of $16,478,071 to additional paid in capital.

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph d

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 1

-Section B

-Paragraph 7, 11A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 21 115 1 false 4 0 false 3 false false R1.htm 00 - Document - Document and Entity Information Sheet http://lifeadvantage.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 01 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://lifeadvantage.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 011 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://lifeadvantage.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 02 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://lifeadvantage.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 03 - Statement - Condensed Consolidated Statements of Stockholders' Equity and Comprehensive Income (Unaudited) Sheet http://lifeadvantage.com/role/StatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity and Comprehensive Income (Unaudited) false false R6.htm 04 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://lifeadvantage.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 06001 - Disclosure - Organization and Basis of Presentation: Sheet http://lifeadvantage.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation: false false R8.htm 06002 - Disclosure - Summary of Significant Accounting Policies: Sheet http://lifeadvantage.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies: false false R9.htm 06003 - Disclosure - Line of Credit Sheet http://lifeadvantage.com/role/LineOfCredit Line of Credit false false R10.htm 06004 - Disclosure - Stockholders' Equity Sheet http://lifeadvantage.com/role/StockholdersEquity Stockholders' Equity false false R11.htm 06005 - Disclosure - Stock-based Compensation Sheet http://lifeadvantage.com/role/StockBasedCompensation Stock-based Compensation false false All Reports Book All Reports Process Flow-Through: 01 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: 011 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 02 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 04 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) lfvn-20120331.xml lfvn-20120331.xsd lfvn-20120331_cal.xml lfvn-20120331_def.xml lfvn-20120331_lab.xml lfvn-20120331_pre.xml true true

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

Condensed Consolidated Statements of Stockholders' Equity and Comprehensive Income (Unaudited) (USD $)	Total	Common Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income/(Loss)
Balance at Jun. 30, 2011	$ (20,808,202)	$ 98,795	$ 67,606,293	$ (88,453,607)	$ (59,683)
Balance, shares at Jun. 30, 2011		98,794,499
Options/Warrants issued for services	880,891		880,891
Exercise of options and warrants	19,306,745	10,954	19,295,791
Exercise of options and warrants, shares		10,954,535
Issuance of restricted stock		149	(149)
Issuance of restricted stock, shares		149,253
Repurchase of company stock	(976,073)			(976,073)
Repurchase of company stock, shares		(678,926)
Reclassification of liability warrants	16,478,071		16,478,071
Foreign currency translation adjustment	12,085				12,085
Net income (loss)	7,637,013			7,637,013
Balance at Mar. 31, 2012	$ 22,530,530	$ 109,898	$ 104,260,897	$ (81,792,667)	$ (47,598)
Balance, shares at Mar. 31, 2012		109,219,361